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ABSTRACT
Design, Fabrication, and Optimization of Miniaturized Devices
for Bioanalytical Applications
Suresh Kumar
Department of Chemistry and Biochemistry, BYU
Doctor of Philosophy
My dissertation work integrates the techniques of microfabrication, micro/nanofluidics,
and bioanalytical chemistry to develop miniaturized devices for healthcare applications.
Semiconductor processing techniques including photolithography, physical and chemical vapor
deposition, and wet etching are used to build these devices in silicon and polymeric materials. Onchip micro-/nanochannels, pumps, and valves are used to manipulate the flow of fluid in these
devices. Analytical techniques such as size-based filtration, solid-phase extraction (SPE), sample
enrichment, on-chip labeling, microchip electrophoresis (µCE), and laser induced fluorescence
(LIF) are utilized to analyze biomolecules. Such miniaturized devices offer the advantages of rapid
analysis, low cost, and lab-on-a-chip scale integration that can potentially be used for point-ofcare applications.
The first project involves construction of sieving devices on a silicon substrate, which can
separate sub-100-nm biostructures based on their size. Devices consist of an array of 200 parallel
nanochannels with a height step in each channel, an injection reservoir, and a waste reservoir.
Height steps are used to sieve the protein mixture based on size as the protein solution flows
through channels via capillary action. Proteins smaller than the height step reach the end of the
channels while larger proteins stop at the height step, resulting in separation. A process is
optimized to fabricate 10-100 nm tall channels with improved reliability and shorter fabrication
time. Furthermore, a protocol is developed to reduce the electrostatic interaction between proteins
and channel walls, which allows the study of size-selective trapping of five proteins in this system.
The effects of protein size and concentration on protein trapping behavior are evaluated. A model
is also developed to predict the trapping behavior of different size proteins in these devices.
Additionally, the influence of buffer ionic strength, which can change the effective cross-sectional
area of nanochannels and trapping of proteins at height steps, is explored in nanochannels. The
ionic strength inversely correlates with electric double layer thickness. Overall, this work lays a
foundation for developing nanofluidic-based sieving systems with potential applications in
lipoprotein fractionation, protein aggregate studies in biopharmaceuticals, and protein
preconcentration.
The second project focuses on designing and developing a microfluidic-based platform for
preterm birth (PTB) diagnosis. PTB is a pregnancy complication that involves delivery before 37
weeks of gestation, and causes many newborn deaths and illnesses worldwide. Several serum PTB
biomarkers have recently been identified, including three peptides and six proteins. To provide
rapid analysis of these PTB biomarkers, an integrated SPE and µCE device is assembled that
provides sample enrichment, on-chip labeling, and separation. The integrated device is a multilayer structure consisting of polydimethylsiloxane valves with a peristaltic pump, and a porous
polymer monolith in a thermoplastic layer. The valves and pump are fabricated using soft

lithography to enable pressure-based sample actuation, as an alternative to electrokinetic operation.
Porous monolithic columns are synthesized in the SPE unit using UV photopolymerization of a
mixture consisting of monomer, cross-linker, photoinitiator, and various porogens. The
hydrophobic surface and porous structure of the monolith allow both protein retention and easy
flow. I have optimized the conditions for ferritin retention, on-chip labelling, elution, and µCE in
a pressure-actuated device. Overall functionality of the integrated device in terms of pressurecontrolled flow, protein retention/elution, and on-chip labelling and separation is demonstrated
using a PTB biomarker (ferritin). Moreover, I have developed a µCE protocol to separate four PTB
biomarkers, including three peptides and one protein. In the future, an immunoaffinity extraction
unit will be integrated with SPE and µCE to enable rapid, on-chip analysis of PTB biomarkers.
This integrated system can be used to analyze other disease biomarkers as well.

Keywords: nanofluidics, microfluidics, thin-film microfabrication, biomarkers, solid-phase
extraction, on-chip labeling, microchip electrophoresis
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1. INTRODUCTION
1.1 BIOMARKERS AND BIOANALYTICAL METHODS
Human disease is defined as disordered or abnormal functioning of cells, organs, or
systems in the body.1 Disease diagnosis at the right time is important so that an effective treatment
can be provided. In old times, disease diagnosis mostly involved observation of abnormal physical
symptoms such as body color, smell, temperature and locomotive movements.2 This diagnostic
method was generally non-specific and diagnosed diseases in late stages. Therefore, alternative
approaches to diagnose diseases at an early stage have been investigated. Advancements in the
fields of genomics, pathology and proteomics have enabled identification of many health- and
disease-related biochemical entities at the molecular or cellular level.3-4 Such biochemical entities
are called biomarkers5-6 and their absence, presence or concentration can indicate a normal or
abnormal condition.7-8 It is helpful to study the concentrations of biomarkers to predict individuals
with a risk of developing a particular disease. In addition, the study of biomarkers should lead to
better management and treatment of diseases.
Biomarkers can be in the form of peptides, proteins, carbohydrates, nucleic acids and
metabolites.9-11 There are many examples of biomarkers linked to human diseases. For example,
aberrantly expressed microRNAs in pancreatic adenocarcinoma tissue can be found in the plasma
as biomarkers for early detection of this malignancy.12 Isolation and quantification of four
microRNAs, miR-21, miR-210, miR-155, and miR-196a, in heparin treated blood can differentiate
between patients and healthy controls. Among these, miR-155 has been identified as a candidate
biomarker of early pancreatic neoplasia. Another example includes amyloid-β1–42 peptide, t-tau,
and p-tau181p which are biomarkers of Alzheimer's disease (AD).13 These three biomarkers are
found altered in cerebrospinal fluid (CSF) when mild AD is present. In mild AD cases, amyloid1

β1–42 peptide has been found to decrease in CSF, whereas an increase in t-tau and p-tau181p is
reported. Typically, definitive AD is diagnosed with an autopsy, but presymptomatic mild AD can
only be diagnosed with biomarkers.14-15 It is believed that full-blown AD develops over a 20 year
period,16 but it is difficult to diagnose it at an early stage without biomarkers that signal the onset
of disease. Likewise, serum concentration levels of three peptides and six proteins (corticotropinreleasing factor, defensin, ferritin, lactoferrin, thrombin antithrombin complex, and tumor necrosis
factor-α receptor type 1) are altered in preterm birth (PTB) cases.17 Three specific peptides formed
by breakdown of inter-alpha-trypsin inhibitor heavy chain 4 protein are significantly reduced in
women several weeks prior to PTB.17 A panel of these nine PTB biomarkers can be analyzed for
early diagnosis of PTB so that an effective therapeutic intervention can be provided to delay the
delivery. Moreover, lipoproteins help in the transportation and storage of cholesterol in the human
body; and high cholesterol levels are correlated with the progression of cardiovascular diseases.18
Ratios of low-density lipoprotein and high-density lipoprotein can be assessed to evaluate the risk
of cardiovascular disease.19-20 Furthermore, elevated levels of alpha-fetoprotein in serum are
correlated to hepatocellular carcinoma.21-22 Similarly, heat shock protein 90 is related to many
cancers and its inhibition can be helpful in cancer therapeutics.23-24
An ideal biomarker should be easy to detect and quantify non-invasively with good
specificity and sensitivity.25 Although the use of a single biomarker as a disease indicator is
convenient, it often results in low sensitivity. For instance, a single peptide (qlglpgppdvpdhaayhpf)
can be used to diagnose PTB, but offers less than optimal sensitivity (65.0%). However, when this
peptide is used in combination with other biomarkers, the sensitivity is increased to 86.5%, with
little change in specificity.17 Therefore, a panel of biomarkers in disease diagnosis can often
improve the reliability of results. In most cases, biomarker concentration levels are in the µg/mL2

pg/mL range;26 therefore, either a very sensitive method is required or biomarkers should be
preconcentrated before analysis.
There are many methods such as liquid chromatography-mass spectrometry (LC-MS),27
immunoassays,28 and lab-on-a-chip (LOC)29-30 technologies that can be used to analyze
biomarkers. LC-MS is a very powerful technique used for initial identification of biomarkers. It
uses liquid chromatography to separate complex analyte mixtures into individual components and
mass spectrometry to distinguish analytes based on their mass-to-charge ratios. Advantages of LCMS include the ability to analyze hundreds of analytes in complex biological fluids like serum,
plasma and urine.31 However, LC-MS is not a method of choice for routine biomarker analysis, as
it lacks the potential for point-of-care diagnosis owing to instrument size and operational
complexity. Moreover, LC-MS generates complex data and requires experienced personnel to
perform the analysis.
Enzyme linked immunosorbent assay (ELISA)32 is a plate-based immunoassay commonly
used in clinical laboratories for analysis of protein biomarkers in solution. Briefly, the target
molecule is immobilized on an adsorbent surface in a 96-well plate and complexed with an enzyme
linked antibody. Enzyme reaction with a substrate produces measurable signal. In the past,
radioimmunoassay was commonly used to estimate the concentration of target.33 Later, it was
replaced with colorimetric methods because radioactivity poses health risks. In a colorimetric
assay, an enzyme, horseradish peroxidase or alkaline phosphatase, reacts with 5-aminosalicylic
acid or phenolphthalein monophosphate, respectively, to produce a colored product.34 However,
other detection methods like fluorescence are also used.35 ELISA can be performed in four formats:
direct, indirect, sandwich, and competitive.36 Sandwich ELISA is the most common format
because it is robust and sensitive. In this assay, the target molecule is sandwiched between two
3

primary antibodies, one of which has an enzyme that reacts with a substrate to produce a colored
signal. ELISA analysis requires expensive reagents like monoclonal antibodies, and is most cost
effective if all wells in the assay plate are used.37 Moreover, ELISA’s sensitivity to peptides is low.
Therefore, there is still a need for analytical techniques that can provide fast and sensitive analysis
of a range of biomarkers at reasonable cost.
LOC is a rapidly growing application of microfluidics in bioanalytical research.38-40 LOC
systems use micro-to-nanoscale fabricated channels, and employ small volumes of fluids. All
essential components required for an analysis are integrated on a small device. Such components
can be of electrical, mechanical, optical or chemical origin.41 The advantages of LOC systems
include automation, portability, rapid analysis, and potential for point-of-care usage. Many
processes such as sample preparation, chemical reaction, product isolation, fluid handling,
analytical separation, and detection are performed with automation on a single chip.42 LOC is a
possible alternative to ELISA because it can prepare samples on-chip with short analysis times.
1.2 NANOFLUIDICS
1.2.1 Overview
Nanofluidics deals with manipulation and study of fluids confined in sub-100-nm
structures.43 Recently, nanofluidics has attracted significant attention in the study of ions, particles,
and biostructures in small dimensions like nanochannels, nanopores, and nanopipets.44
Nanofluidics is still in its infancy, but it is a rapidly growing research area due to novel nanoscale
phenomena.45 Developments in the microelectronic industry, especially in micro and
nanofabrication, have further encouraged interest and progress in nanofluidics.46 Nanofluidics has
potential for application in various fields like electronics, mechanics, separation science, etc.47-48
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For example in separation science, promising results in pre-concentration and separation of nucleic
acids have been obtained using nanocapillaries with diameters of hundreds of nanometers.49-50
Moreover, there are numerous biomolecules which have sizes in the sub-100-nm range, such as
proteins, lipoproteins, nucleic acids, and viruses. These biostructures are often related to various
human diseases. For example, hepatitis B virus causes liver disease,51 and the concentration
distribution of LDL/HDL is related to cardiovascular disease.20 Therefore, it could be helpful to
study these biomolecules using nanofluidics, which offers dimensions comparable to the sizes of
these biostructures.
Nanofluidics exhibits many characteristics, which make it different from bulk fluidics; for
example, nanofluidic channel dimensions (1-100 nm) are comparable to the sizes of many
biostructures (proteins, nucleic acids, and lipoproteins) and the electric double layer (EDL)
thickness (1-100 nm).52 Such a close correlation in dimensions and EDL in nanochannels can
significantly affect ion, particle and fluid transport. Two important nanofluidic characteristics
useful in my studies are capillary action and EDL.
Similar to the microscale, the forces generated by the curvature of a liquid meniscus in a
nanochannel produce capillary action. The meniscus velocity produced by capillary action in
rectangular nanochannels is given in equation (1.1) below,53
ν≈

𝑑𝑑γcosФ
4𝑙𝑙η

(1.1)

where ν is the meniscus velocity, d is the height of the rectangular channel, γ is the surface tension
of the liquid, Ф is the dynamic contact angle between the liquid meniscus and the vapor phase, 𝑙𝑙

is the distance between meniscus and the channel inlet, and η is the liquid viscosity. Capillary
action is a spontaneous phenomenon that allows the filling of nanochannels and analyte transport,
eliminating the need for external voltage or pressure controllers.
5

An EDL structure is formed when a surface is exposed to ionic species in solution. For
example, silicon surfaces have weakly acidic silanol groups, which are negatively charged in basic
conditions. This results in accumulation of some positively charged species at the silicon surface.
These positively charged species form a fixed layer closer to the surface and a movable diffuse
layer next to the fixed layer. These two layers constitute together the EDL, with a characteristic
thickness given by the Debye length (κ−1).54 The thickness of the Debye length varies from 1 to
100 nm depending on the concentration of the ionic species in solution as given in equation (1.2)
below,
κ−1 = [ƐrƐ0RT/2F2C0]1/2

(1.2)

where Ɛr is the dielectric constant, Ɛ0 is the permittivity of free space, R is the gas constant, T is
the absolute temperature in Kelvin, F is the Faraday constant, and C0 is the molar concentration of
the electrolyte. The effects of EDL become prominent in nanochannels due to comparable
dimensions. For example, in nanochannels having at least one dimension in the 5-100 nm range,
the EDL on opposite walls can overlap and affect the transport of analytes by changing the
effective opening size of the nanochannel or ion concentration polarization.55-56
1.2.2 Materials and nanochannel fabrication methods
Many factors need to be considered in choosing a fabrication material for nanochannels,
for example, cost; ease of fabrication; and surface, optical, and mechanical properties. To date, a
wide range of materials has been explored for nanochannel fabrication including inorganic (silicon,
glass and quartz) and organic [polydimethylsiloxane (PDMS), polymethylmethacrylate (PMMA),
and polycarbonate (PC)].52
Among these materials, silicon is the most common substrate on which nanochannels are
fabricated owing to well-developed fabrication techniques and reasonable cost. However, silicon
6

is not transparent to visible light, which makes visual observation of fluid impossible. Other than
silicon, glass and quartz are also used to make nanochannels due to their optical clarity and
electrical insulation.57-58 Furthermore, the nanochannel wall material is also important.
Nanochannel walls can be formed with silicon dioxide, silicon nitride, or other materials deposited
using chemical or physical vapor deposition.59-60 The nature of the wall material results in different
surface properties like charge, electrical insulation, hydrophobicity/hydrophilicity, roughness, and
biocompatibility.52 Such properties are important as they affect the transport of fluids and particles
through the nanochannels. Unlike silicon, organic materials such as PDMS, PMMA, and PC are
less common for nanochannel fabrication, but they are increasingly being considered owing to low
material and fabrication cost and optical transparency.61
Nanochannel fabrication is usually performed in a clean room facility because particles can
block nanochannels and can cause problems in substrate bonding.62 Nanochannel fabrication can
be categorized as either top-down or bottom-up;63 I will first describe top-down in the following
paragraphs, followed by bottom-up. Top-down methods involve reducing large-scale patterns into
small structures and can be divided into three categories: bulk/film nanomachining, surface
nanomachining, and mold machining.
In bulk/film nanomachining, structures are created either by etching trenches in the bulk of
a substrate or a film deposited on a substrate.64 It uses standard photolithography to define
structures on the substrate, followed by wet or dry etching. Reactive ion etching is a common dry
etch method, and produces vertical sidewalls.65 Moreover, anisotropic wet etching using aqueous
KOH or tetramethylammonium hydroxide can produce smooth vertical walls;66 but it requires the
correct crystal oriented substrate.67 Next, the prepared structures are sealed by bonding to another
flat substrate. Thermal and anodic bonding processes are commonly used for enclosing
7

nanochannels,68 but their effectiveness is affected by particle contamination. Bulk/film
nanomachining can suffer from channel collapse while performing the bonding step,63 but this can
be avoided by proper selection of channel geometry, wafer thickness, substrate hardness, and
adhesion surface energy.62
The second top-down fabrication technique uses sacrificial layers to define nanochannel
structures;69 the sacrificial layers are then dissolved to form hollow nanochannels. Briefly, surface
nanomachining involves deposition of a bottom layer and sacrificial material.70 After this,
patterning of the sacrificial layer using UV photolithography and wet/dry etching occurs. Resulting
structures are covered with a top capping layer (often silicon dioxide), and the top layer is patterned
to access the sacrificial material during etching. Finally, the sacrificial material is etched and
results in hollow nanochannels. Sacrificial materials commonly used are polysilicon, amorphous
silicon, and metals.71-73 This method has drawbacks in that part of the capping layer needs to be
removed to access the sacrificial layer and etching of the sacrificial layer takes a long time (1-3
days). However, this process produces uniform height nanochannels, because the channel height
is defined by the thickness of the sacrificial layer.74
In mold-machining or nanoimprint lithography, a master mold is prepared by either
patterning of layers of photoresist using photolithography or electron beam lithography or using a
focused ion beam to pattern Si directly.75-76 The master mold is used to transfer features into a
material.77 The mold can be either directly pressed against a material like PMMA or a thin resist
film coated on a Si substrate to duplicate mold features, which are transferred by heating the
material close to its glass transition temperature.78-79 Alternatively, a mixture of monomer and
curing agent can be poured onto a mold, cured, and then peeled off.76 Mold machining is a high

8

throughput technique with low fabrication cost, and capability of producing smooth and vertical
sidewalls.
Bottom-up fabrication is a new approach that is being explored for nanochannel
fabrication. In the bottom-up method, atoms and molecules are assembled to make nanostructures
by atomic layer deposition, molecular self-assembly, sol-gel nanofabrication, or DNAscaffolding.80 This method has potential to make small structures (2-10 nm) with low reagent
consumption and minimal requirement of semiconductor-processing instruments.63, 81 On the other
hand, challenges include control of assembly, surface preparation, and requirement of ultra-pure
reagents.80 Min et al.82 used a ~1 nm wide graphene nanoribbon fabricated by a bottom-up
approach to build a nanochannel in Si3N4, which was used for fast DNA sequencing.
1.2.3 Size-based separations in nanochannels
So far, much of the nanofluidics research has focused on fundamental studies,45 because
phenomena at the nanoscale are not yet well understood. However, many scientists have been
successful in designing nanostructures to separate biomolecules based on their size, charge or
length.83 Size- and length-based separations are common because of their dimensional overlap
with nanofluidic structures. Nanofluidics have been used to study nucleic acid separations in
particular. Han et al.50 fabricated nanofluidic channels consisting of alternating deep and shallow
regions to separate long DNA. The molecules changed their conformations while passing through
the thin and thick regions as an electric field was applied across the channel length. The mobility
of long DNA molecules in the shallow regions was greater than short DNAs due to a favorable
entropic contribution. This created electrophoretic mobility differences, and resulted in efficient
separation of DNA molecules without the need of a gel matrix. In 2006, Fu et al.84 published a
study presenting Ogston-like sieving of rodlike DNA molecules in periodic nanofluidic filter
9

arrays. DNA molecules have been also fractionated by applying forward and reverse bias
asymmetric voltage pulses across the nanochannel length.85 There are few studies on separation of
proteins in nanofluidic channels, as fabrication of nanochannel dimensions comparable to protein
sizes (1-20 nm) is challenging and channels are susceptible to clogging. Zeng et al.86 fabricated an
ordered, 3D nanofluidic sieve in a microchannel using colloidal self-assembly, which allowed
separation of a wide range of proteins (20-200 kDa) and dsDNA (0.05-50 kbp) by Ogston-like
sieving and entropic traps, respectively. Inglis et al.87 demonstrated the separation of Rphycoerythrin (240 kDa) and streptavidin (54 kDa) in silica-based nanochannels by concentration
gradient focusing. All the studies described above used voltage to drive biomolecules through
sieving channels. Moreover, the sieve size was not precisely controlled, especially for protein
separation. In this dissertation, I describe fabrication of sieving nanochannels in which sieve
openings in the 10-100 nm range can be defined accurately. Protein molecules are driven into
nanochannels by capillary flow, which causes size-based separation at the constrictions in the
nanochannels.
1.3 MICROFLUIDICS
1.3.1 Overview
Microfluidics deals with the study and manipulation of fluids in microfabricated structures
with a few to hundreds of micrometer dimensions.88 First, I present a brief history of microfluidicbased system developments. In the 1970s, the first microfabricated device in a silicon wafer was
used for gas chromatography.89 Despite the fact that the miniaturized gas chromatograph could
separate simple compound mixtures in a few seconds, it did not get much attention from the
separation science community until years later. In 1990, a liquid chromatograph was fabricated on
a silicon wafer although it was not demonstrated for actual separations.90 At that time, Manz et
10

al.91 also coined the term micro total analysis system (µTAS), or a setup capable of performing all
sample handling steps extremely close to the place of measurement. An early attempt at a µTAS
in 1992 used microfabricated glass devices to perform sample injection through electroosmotic
pumping and electrophoretic separation on a microchip.92 The number of papers published on
miniaturized devices abruptly increased in 1994 as many groups joined in microfluidic research.93
Since then, microfluidics research has continued growing, and more complex processes such as
sample extraction, filtration, derivatization, alternative separation, and detection schemes have
been incorporated in miniaturized devices.
Microfluidic systems are the result of combining concepts from multiple disciplines like
chemistry, physics, and engineering on the same platform. Microfluidics are used in both chemical
and biological analysis, and offer many advantages. For example, very small quantities of sample
and reagents are required; and device size is small, which reduces fabrication cost, offers
portability for field applications, and reduces diffusion distances, resulting in better mixing.94
Moreover, many laboratory processes can be integrated on a single device to provide complete
analysis in a µTAS.95 Integrated processes include sample preparation, fluid flow control through
pumps and valves, sample mixers, and detection.96-98 Fluid transport in microfluidic devices can
be accomplished using either voltage or pressure.99 The electrokinetic approach is more common
because of simple operation, but it also suffers from inherent limitations including charge bias,
bubble formation, and reliance on channel wall and buffer properties. Thus, pressure-based
controllers have been developed that use external or on-chip pumps and valves.
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1.3.2 Materials
Broadly, microfluidic device fabrication materials can be divided into three categories:
inorganic, polymeric, and paper;38 here, I will focus only on the first two. The initial microfluidic
devices were fabricated in silicon due to the well-established methods for silicon processing. Glass
was also used early on because of its similar surface chemistry to silicon. Later, many polymerbased materials were explored to make microfluidic devices. The selection of material is important
in determining the cost as well as the operational performance of the device. Usually, three
important factors including required function, scale of integration, and application are considered
in choosing the device material. Some of the material properties like flexibility, air permeability,
solvent compatibility, optical clarity, non-specific adsorption, and compatibility with fabrication
methods are critical in selection of a material.
Many materials have been developed to make microfluidic devices at low cost, with simple
fabrication, and good reliability. Silicon and glass are the main inorganic materials used in
microfabrication of microfluidic devices. Due to the semiconductor properties of silicon, it allows
integration of electrical circuitry in making a µTAS. However, the semiconducting nature of
silicon makes electrokinetic operations problematic due to leakage of current. Moreover, silicon is
not transparent to visible light, which makes fluid imaging and fluorescence detection challenging
in all-silicon devices. Silicon has surface silanol groups (Si-OH) which allow tailoring of surface
chemistry using silanes. Glass offers similar surface chemistry to silicon, transparency to visible
light, and compatibility with biological samples. Silicon and glass are both gas impermeable and
rather inflexible, so they cannot be used to make flow controllers like valves and pumps. However,
they can be used in hybrid devices along with polymers to overcome some of these limitations.
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Polymers are replacing silicon and glass as microfluidic device fabrication materials owing
to their amenable properties. For example, polymers are usually optically transparent, moldable,
inexpensive, and good for mass production. Polymer materials are divided into thermoplastic and
elastomeric types. Thermoplastic polymers can be molded or embossed above their glass transition
temperatures, and then retain patterns when cooled down; they offer the advantages of easy
micromachining, impermeability to gases, and optical transparency.100 Some commonly used
thermoplastics include PMMA, cyclic olefin copolymer (COC), PC, and polystyrene (PS). PMMA
is a common device fabrication material that has a low glass transition temperature (~105 oC)
which allows easy hot embossing and injection molding. Moreover, PMMA is optically clear,
impermeable to gas and small molecules, and biocompatible.101 COC offers a low glass transition
temperature (~90 oC), optical clarity, and compatibility with organic solvents;102 however, COC’s
surface is hydrophobic and requires modification for protein analysis. Thermoplastics are
relatively rigid and therefore not useful to make on-chip valves and pumps.
On the other hand, elastomers are flexible and capable of forming pneumatic valves and
pumps, which make their use in integrated devices plausible. PDMS is the most common
elastomeric polymer and is widely used for making microdevices.94,

103

PDMS offers gas

permeability, optical transparency, and rapid fabrication. The gas permeability of PDMS enables
its use in making devices for cell analysis. Moreover, the flexibility of PDMS has been used to
make pneumatic valves and membrane-based pumps to allow pressure-actuated fluid handling.
PDMS-based microchannels are hydrophobic, and suffer from non-specific adsorption and bubble
formation. However, there are methods such as oxygen plasma treatment and surface coatings to
reduce hydrophobicity and non-specific adsorption in PDMS devices.104
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1.3.3 Fabrication methods
Microfluidic devices are fabricated using a variety of methods including photolithography,
wet/dry etching, laser ablation, micromachining, replica molding, hot embossing, and injection
molding.105-106 A fabrication method is selected based on cost, speed, material properties, critical
dimensions, and instrument availability. Broadly, device fabrication can be divided into additive
and subtractive methods. In additive methods, microstructures are created on the surface of the
material, whereas subtractive methods involve formation of structures within the material.
Silicon and glass devices are mostly fabricated in a cleanroom facility using techniques
from the microelectronics industry, such as photolithography, wet and dry etching, and thin film
deposition. In photolithography, a mask pattern is transferred to a light-sensitive photoresist coated
on a substrate by exposing selected areas to UV light. The exposed areas either become soluble or
insoluble in resist developers based on the type of resist used, as shown in Figure 1.1. Features are
created on the substrate by wet or dry etching of uncovered areas. Then, the patterned features are
bonded to a flat substrate to form enclosed channels.
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Figure 1.1 Schematic showing UV photolithography on a silicon wafer coated with (left) positive and
(right) negative photoresist.

In other cases, structures formed on a substrate as described above or on a patterned
photoresist layer can be used as a master mold to create features in polymers by soft lithography
or hot embossing.107 Casting elastomeric materials like PDMS by replica molding involves pouring
a mixture of PDMS monomer and cross linker directly onto the master mold (see Figure 1.2).
Next, the PDMS mixture is thermally cured to duplicate mold features into the polymer. The cured
PDMS is peeled off and bonded reversibly or irreversibly to another PDMS, glass, thermoplastic
or silicon substrate to form enclosed microchannels. Moreover, multiple layers of PDMS can be
stacked or bonded to make complex 3D devices with multiple functions.
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Figure 1.2 Schematic showing fabrication of a microchannel in PDMS by replica molding.

In hot embossing (see Figure 1.3), a flat thermoplastic material is pressed against a
patterned substrate (silicon or metal), and the assembly is heated above the glass transition
temperature of the polymer.108 This results in transfer of substrate features into the polymer; then,
the imprinted polymer is bonded to a flat substrate using heat, solvent or adhesives. Hot embossing
is a straightforward and inexpensive method to make microdevices.
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Figure 1.3 Schematic showing hot embossing and thermal bonding processes to form a microchannel in a
thermoplastic polymer.

1.3.4 Pumps and valves
There is a wide range of mechanisms that can be used to manipulate fluid in microchannels;
for example, capillary action, electroosmotic flow (EOF), vacuum, external pumps, membraneactuated pumps, electrohydrodynamic pumps, and magnetohydrodynamic pumps.38, 105 External
pumps or vacuum have been used in many studies, but they require larger off-chip hardware, which
is contrary to the goal of miniaturization. An electroosmotic pump (EOP) is a non-mechanical
pump, driving fluid using EOF generated by the interaction of the electric field and EDL.109 EOPs
are easy to integrate on-chip and produce constant flow rates. Moreover, fluid velocity and
direction can be manipulated by adjusting the voltage and polarity. However, EOPs can be only
used for conductive liquids in narrow (<100 µm) channels, and surface adsorption, Joule heating
17

and bubble formation affect pump performance. In a membrane-actuated pump, liquid is displaced
in pulses by sequential actuation of pneumatic valves placed in series, as shown in Figure 1.4.110
Membrane-actuated pumps allow easy control over flow rate and direction by adjusting the valve
actuation frequency and sequence, respectively. However, the downside is that membrane-actuated
pumps require external connections and off-chip hardware.

Figure 1.4 Schematic of a membrane-actuated peristaltic pump. (A) Top-view of a five-valve pump in the
unactuated state. (B) Cross-sectional side-view of a five-valve pump showing the sequence of valve
actuation over the course of time.

Furthermore, liquid flow through microchannels can be controlled or confined using onchip valves. There are many types of microfluidic valves like pneumatic, piezoelectric, magnetic,
shape-memory alloy, and check valves.38, 111 PDMS is the most common material used for making
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on-chip pneumatic valves owing to its elastic nature.112 Pneumatic valves are widely used due to
easy integration and simple actuation mechanism.113 However, they require external pneumatic
controllers like solenoids for their operation.
1.3.5 Microchip electrophoresis
Microchip electrophoresis (µCE) is a miniaturized version of capillary electrophoresis,
offering several advantages such as lower reagent consumption, speed, and ability of integration
with other processes on-chip.114-115 Capillary and µCE separate analytes based on their migration
in an electric field. Analytes acquire a velocity in an electric field based on equation (1.3),
v=µeE

(1.3)

where v is the migration velocity, µe is the electrophoretic mobility, and E is the applied electric
field. An ionic analyte in solution reaches a steady state velocity when the accelerating force
(equation 1.4) is balanced with the frictional force (equation 1.5),
Fa = qE

(1.4)

Ff = 6πηrv

(1.5)

where q is the analyte charge, η is the viscosity, and r is the hydrodynamic radius of the analyte.
Under steady state, combining equations (1.3), (1.4), and (1.5),
µe = q/6πηr

(1.6)

indicating that at constant solution viscosity the electrophoretic mobility depends on analyte
charge and radius. According to equation (1.6), smaller molecules or ones with higher charge move
faster than larger molecules or ones with lower charge, which results in separation.
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Movement of analyte is not only governed by electrophoretic mobility but also by EOF, or
the movement of bulk fluid under an electric field. Typically, the surfaces of microchannels and
capillaries carry a negative charge, and to counter-balance this charge, positive ions from the
solution align on the surface and form an EDL. Under an applied voltage, the cations near the
channel wall move towards the cathode and carry the water of hydration with them. This results in
bulk flow towards the cathode, called EOF. The electroosmotic mobility (µeo) is given in equation
(1.7) below,
µeo =

εζ
4πη

(1.7)

where ε is the dielectric constant, and ζ is the zeta potential. The electroosmotic mobility is
inversely proportional to the viscosity of the medium and directly proportional to the zeta potential.
Thus, EOF can be reduced by coating the capillary wall to decrease the zeta potential and increase
the surface viscosity. The apparent mobility (µapp) of an analyte is a combination of the
electrophoretic and electroosmotic mobilities as shown in equation (1.8).
µapp = µep + µeo

(1.8)

Combining equation (1.3) and (1.8), the apparent migration velocity (vapp) of an analyte is given
by equation (1.9).
vapp = µappE

(1.9)

As a result of typical EOF, neutral analytes move in the same direction and with the same velocity
as the EOF. The mobility of cations is increased due to EOF in the same direction, while the
mobility of anions is reduced due to opposing EOF.

20

In µCE, device operation involves three steps: sample injection, electrophoretic separation,
and detection. Sample injection is generally performed by electrokinetic flow.116 The most
common electrokinetic injection modes are floated, pinched and gated injections.98, 117 Pinched
injection allows loading of small volumes of samples defined by the intersection geometry. Crossshaped or double-T-shaped geometries are common and shown in Figure 1.5.115 Briefly, voltage
is applied between reservoirs 1 and 2 while keeping reservoirs 3 and 4 at ground. For separation,
voltages are reconfigured to pinch a small sample plug at the channel intersection for separation
by applying high voltage at reservoir 4; small pull back voltages on reservoirs 1 and 2; and ground
voltage at reservoir 3. Pinched is the most common type of injection, but requires injection times
that can be as long as the separation times (10-150 s). Pinched injection has been further refined
using narrow channels at the intersection for improved resolution.118 All electrokinetic injection
methods have the drawback of sample mobility bias caused by the injection voltage. Hence, the
least charged and largest molecules are under-injected compared to the most charged and smallest
molecules.
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Figure 1.5 Sample injection geometries in µCE. (A) Cross-shape and, (B) double T-shape. Reservoirs are
1: sample, 2: sample waste, 3: running buffer, 4: separation waste.

1.3.6 Detection
In µCE, various detection modes have been used such as optical, electrochemical, and mass
spectrometry.38, 105 Optical methods are the most common because they provide detection limits
comparable to mass spectrometry and can be carried out with the simplest device designs. Among
optical methods, fluorescence, chemiluminescence and UV absorbance are popular.119 Laserinduced fluorescence (LIF) is widely used owing to its detection limits. However, a drawback of
LIF is that, in most cases, it requires derivatization of analytes with dyes such as fluorescein. Figure
1.6 shows a schematic of an LIF detection setup. LIF systems include a laser, focusing and
wavelength selection optics, a photomultiplier tube (PMT) or charged-coupled device (CCD) to
record

fluorescence,

and

other

hardware

including

a

microscope,

computer,

etc.

Chemiluminescence does not require an external light source because it utilizes light emitted from
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a chemical reaction between molecules. UV absorbance is label-free and used in conventional
electrophoresis, but its detection limits are far higher (µg/mL) than for LIF or chemiluminescence.

Figure 1.6 Schematic showing an LIF detection system.

1.4 SAMPLE PREPARATION
Good sample preparation is at the heart of any chemical analysis. For example, sample
preparation can involve filtration, purification, preconcentration and derivatization.38 These
benchtop methods can be time consuming, solvent-intensive, and sample-inefficient. Microfluidics
offers the potential of integrating sample preparation procedures on a single device.99, 120-122 Such
integration allows automation, rapid analysis, and small sample and reagent consumption.
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1.4.1 Extraction and purification
Liquid-liquid and solid phase extraction (SPE) are common techniques used to remove
desired analyte from the sample matrix. Liquid-liquid extraction involves transfer of analyte from
one solvent to another based on solubility and is widely used to prepare food and environmental
samples.123 Drawbacks of liquid-liquid extraction are the use of large quantities of solvents and
inefficient analyte transfer with a single extraction. On the other hand, in SPE, analyte is adsorbed
on a solid support.124 The availability of a wide variety of adsorbents makes SPE a versatile
method. Analyte is adsorbed based on four types of interactions: hydrophobic (non-polar),
hydrophilic (polar), ionic, or ligand-based (immunoaffinity).125 Figure 1.7 shows the sequence of
events performed in SPE. In general, SPE involves conditioning of the support with a weak eluent
to activate surface functional groups. Next, sample is loaded onto the adsorbent, and unretained
material is washed away. Finally, retained analyte is eluted. SPE adsorbents are prepared by
packing surface-functionalized silica particles, in-situ UV photopolymerization of monolithic
structures, and fabrication of porous membranes.126-129 Silica beads have silanol groups on their
surfaces which can be bonded to alkyl or aryl groups using silane chemistry. Butyl, octyl, and
octadecyl are commonly used alkyl chains bonded to silica particles to extract non-polar to
moderately polar analytes. Monolithic structures have gained interest in microfluidics because they
are prepared in-situ, hence avoiding the difficulty of packing. Moreover, their surface areas and
through pore sizes can be tuned by adjusting the porogens in the monolith solution.
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Figure 1.7 Schematic showing various steps in SPE. (A) Solid-support conditioning. (B) Sample loading.
(C) Sample elution.

1.4.2 Preconcentration
Another important procedure in sample preparation is preconcentration, in which an
analyte of interest is concentrated before introducing it into an analytical instrument.130 For
example, biomarkers in their native matrix are usually in the µg/mL-pg/mL range,17, 26 so to
improve their detection, they are often preconcentrated. The common methods of on-chip sample
preconcentration are SPE and filtration, in which analyte solution is passed through a porous
structure or a membrane, which results in surface interaction-based and size-based retention,
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respectively.131 Next, the analytes are eluted in concentrated form and analyzed. Preconcentration
on monoliths and packed columns follows the same principles as SPE.
1.4.3 On-chip fluorescent labeling
LIF provides the lowest limits of detection in microfluidics, but requires labeling of
analytes in most cases. Fluorescent labeling involves reaction between a functional group and a
reactive dye. There are many functional groups like amines, thiols, and carboxylic acids for which
fluorescent dyes are available commercially. Proteins are mostly labeled on primary amine groups
available on lysine residues and the N-terminus. For labeling, a mixture of protein and dye is
incubated at room temperature for 1 to 24 hours; faster labeling is advantageous as it saves time
and can be used in on-chip analysis. After incubation, unreacted dye is filtered off, commonly
using mass cutoff filters in an ultracentrifuge. This process is time consuming, and high protein
concentrations (1-5 mg/mL) are required for labeling, which often results in sample waste. These
drawbacks of conventional labeling can be addressed by labeling samples on-chip. On-chip
labeling is faster and uses smaller quantities of reagents. Moreover, prepared sample is used
immediately so photobleaching of dye during storage is not an issue. On-chip labeling also
produces the possibility of integrating sample preparation and separation techniques on-chip for
automation. On-chip labeling can be performed by flowing dye solution over adsorbed molecules
in SPE columns. After rinsing the unreacted dye, labeled molecules are eluted.
1.5 DISSERTATION OVERVIEW
Biomarker analysis provides an excellent opportunity to diagnose diseases at an early stage,
such that effective treatment can be initiated. However, existing analysis methods are expensive,
time consuming, require experienced personnel, or are inconvenient for point-of-care applications.
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Microfluidic and nanofluidic devices open up a new frontier and provide an opportunity to address
the existing challenges in biomarker analysis. Nanofluidic structures are comparable to
biomolecular sizes and, therefore, can be used to analyze molecules based on their size differences.
Microfluidics can provide a complete automated analysis tool by integrating multiple processes
such as on-chip sample enrichment, labeling, separation, and detection on a single platform. This
dissertation focuses on developing new miniaturized devices for biomarker analysis. Chapters 2
and 3 develop a novel method for protein sieving using a size-based nanofluidic approach.
Chapters 4, 5, and 6 focus on developing microfluidic-based devices that integrate SPE and µCE
to provide PTB biomarker analysis. A brief overview of Chapters 2-6 in this dissertation is
provided below.
In Chapter 2, I present the fabrication of an array of planar nanochannels with at least one
dimension below 100 nm using thin-film microfabrication techniques. These nanochannels contain
height steps where sub-hundred-nm particles are trapped size-selectively. I studied size-dependent
fractionation of five proteins in five different height step devices. I evaluated the effects of protein
size and concentration on trapping at the height steps, and helped in developing a mathematical
model to predict trapping behavior. I also showed that altered buffer ionic strength influences the
trapping behavior of proteins at height steps.
In Chapter 3, I fabricated single-height and height-step nanochannels with SiO2 and Ta2O5
on the channel surface. I studied the effect of heat-treatment on protein signal at nanochannel exits.
A heat-treatment protocol was developed to decrease the number of surface silanol groups in SiO2
channels, which resulted in increased protein signal at the nanochannel exits. A similar effect was
observed with Ta2O5 channels. This heat treatment reduced protein adsorption and improved signal
at the channel exits.
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In Chapter 4, I evaluated off-chip labeling of preterm birth biomarkers using capillary and
microchip electrophoresis. An off-chip labeling protocol was developed for labeling PTB peptides.
Additionally, time- and dye-dependent labeling of ferritin (Fer) was studied. A protocol for
microchip electrophoresis was developed to separate four PTB biomarkers including three peptides
and one protein.
In Chapter 5, I present fabrication processes for making on-chip solid phase extraction and
separation modules, and their subsequent integration. On-chip pneumatic valves and a peristaltic
pump were used to provide pressure-actuated fluid flow. Monolithic columns were fabricated to
perform on-chip SPE and labeling.
In Chapter 6, I demonstrate operational aspects of the devices fabricated in Chapter 5.
Channel dimensions were modified to improve valve actuation and flow rates. An SPE module
was developed by individually studying Fer and dye retention and elution, three- and five-valve
pumps, and Fer enrichment. On-chip labeling of Fer was also performed with labelled Fer
separated by µCE, after sample injection and plug capture using microfabricated valves and pump.
In Chapter 7, I present my conclusions from these studies and describe possible expansions
of the reported work.
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2.

THIN-FILM

MICROFABRICATED

NANOFLUIDIC

ARRAYS

FOR

SIZE-

SELECTIVE PROTEIN FRACTIONATION*
2.1 INTRODUCTION
Various biostructures in the sub-hundred nanometer range are associated with human
diseases.1-3 For example, hepatitis B virus causes liver disease,4 and lipoprotein size and
concentration distribution is linked with cardiovascular disease.5 High density lipoprotein (HDL)
and low density lipoprotein (LDL), with diameters in the 5 to 25 nm size range, are important in
cardiovascular risk assessment. Additionally, aggregation in pharmaceutical protein formulations
is a major issue that can render a formulation physically unstable.6 Therefore, size-selective
fractionation and distribution studies of these molecules or particles are an important analytical
research area.
There are several techniques available to separate biomolecules based on size; for example,
size exclusion chromatography (SEC), field flow fractionation (FFF), membrane filtration,
ultracentrifugation, and electrophoresis. However, these techniques all have limitations. SEC can
reproducibly separate molecules based on size but requires a >10% difference in molecular weight
for adequate resolution.7 FFF can separate molecules and particles in the size range of 1 nm to 50
µm based on their interaction with an external applied field.8 However, FFF requires a complex
setup and experienced personnel. Membrane filtration fractionates based on a single cutoff size
but suffers from sample loss, fouling, and pore clogging.9 Ultracentrifugation, which separates
molecules based on size or density, is slow (>24 h) and energy intensive.10-11 Gradient gel
electrophoresis can separate biomolecules with high resolution based on electrophoretic mobility,
but this technique is time consuming (~18 h) and requires skilled personnel.12 Thus, improved
*Adapted with permission from Kumar, S.; Xuan, J.; Lee, M. L.; Tolley, H. D.; Hawkins, A. R.; Woolley,
A. T., Thin-film microfabricated nanofluidic arrays for size-selective protein fractionation. Lab Chip 2013,
13, 4591-4598.
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methods for size fractionation of biostructures, especially in the 5-100 nm size range, are needed
to overcome the disadvantages of current approaches.
Nanofluidics studies the behavior and manipulation of fluids confined in 1-100 nm
dimensions.13 In these small size scales, fluids exhibit phenomena different from those at
macroscale or even microscale levels due to overlap of these dimensions with molecular sizes and
the electric double layer (EDL) formed on channel walls. Nanofluidics is a growing field of
research because various biostructures including proteins, nucleic acids, and viruses have sizes
comparable to nanofluidic dimensions. Ongoing developments in micro and nanofabrication,
including nanoimprint lithography, sacrificial approaches, etching, and bonding methods, have
furthered the field of nanofluidics by enabling the fabrication of controlled nanostructures.14
Nanochannels smaller than 5 nm in width have been made by using focused ion beam milling.15
There are many fields such as biophysics and separation science where nanofluidics is now being
evaluated,16 for example in pre-concentration and separation of proteins and nucleic acids,17-18 and
single molecule DNA sequencing.19 There are several challenges in making nanoscale devices,
such as the fabrication costs imposed by high-resolution methods like focused ion beam milling
and e-beam lithography; and issues with precision in channel dimensions, particularly after
bonding steps. These challenges are especially problematic for fabricating nanochannels with
dimensions below 30 nm.
An EDL is formed on surfaces when in contact with ionic solution, and it becomes
prominent when critical dimensions drop below 100 nm.20-22 The EDL thickness can range from
sub-nm to 100 nm and correlates inversely with buffer ionic strength. In my sieving system, the
EDL formed on the channel walls can extend deep into the channel and change the effective height

44

of a nanochannel. This altered cross-sectional area can influence the transport of charged
biostructures through nanochannels depending on their interaction with the EDL.
Here, I have developed a nanofluidic-based sieving system that provides size separation of
structures such as proteins in the ~10 nm diameter range. This system consists of an array of 200
parallel nanochannels having height steps from 100 nm down to 15-30 nm. These readily
adjustable heights can be achieved using widely available, standard thin-film micromachining
methods. Capillary action draws solutions through the nanochannels, with larger molecules being
trapped at the height steps while smaller molecules reach the ends of the nanochannels. I have
evaluated this system with five model proteins whose sizes approximate those of HDL and LDL.
I have measured the effects of protein diameter and nanochannel step height on trapping behavior
of proteins. Additionally, the influence of protein concentration on trapping was studied. These
data provide an understanding of the correlation between protein size and height step, information
that I have compared to a predictive model of size-based nanosieving. This chapter also includes
a study on buffer ionic strength effects on trapping behavior of proteins in nanochannels. This new
system offers advantages over current nanoscale fractionation methods in terms of device size and
simplicity, reduction of reagent volumes, and assay speed.
2.2 EXPERIMENTAL
2.2.1 Materials and reagents
As shown in Table 2.1, five proteins of different diameters from 3.5-17 nm23-26 were
obtained from Sigma-Aldrich, St. Louis, MO. Each protein was labeled with fluorescein
isothiocyanate (FITC, Invitrogen, Eugene, OR) for fluorescence detection. A 4 mg/mL stock
solution of FITC was prepared in dimethyl sulfoxide (DMSO, Sigma-Aldrich), and stock solutions
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of 2-3 mg/mL of each protein were prepared in 100 mM bicarbonate buffer at pH 9. Then, 20 µL
of FITC stock solution was added to 250 µL of protein stock solution and incubated in the dark
for 24 h at room temperature. Next, excess dye was removed from the protein solution using
centrifugal membrane filters (Millipore, Billerica, MA) with mass cutoffs of 10 kDa (Mb), 30 kDa
(Hb), and 100 kDa (Fer, Ct, and Tg). Protein solutions were rinsed multiple times with 10 mM
bicarbonate buffer (pH 8.3) in an Eppendorf microcentrifuge (Hauppauge, NY) at 10,000 rpm for
6-8 min until a clear filtrate was obtained. Finally, bicarbonate buffer was replaced with 100 mM
Tris-HCl buffer (pH 8.3) containing 2 mM sodium azide to make up the final volume of protein
stock solution. The final stock concentration of each protein was measured using a Nanodrop
spectrophotometer (ND-1000, Wilmington, DE). Subsequently, 1.0, 0.5, 0.1, and 0.05 mg/mL
solutions of each protein were prepared volumetrically from the stock solution in 100 mM TrisHCl buffer (pH 8.3), containing 1 mM sodium dodecyl sulfate (SDS, Shelton Scientific, Peosta,
IA) and 0.12% v/v Triton X-100 (Sigma-Aldrich) as surfactants. I also prepared 0.5 mg/mL
solutions of Tg and Ct in 1.0, 10.0, 50.0, and 100.0 mM Tris-HCl buffer (pH 8.3), containing 1
mM SDS and 0.12% v/v Triton-X-100 as surfactants. All solutions were stored at 4 oC and
vortexed before use to make a uniform solution.
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Table 2.1 Proteins of different sizes used in nanosieving experiments.

Protein

Abbreviation

Molecular weight (kDa)

Diameter (nm)

Myoglobin

Mb

17

3.5

Hemoglobin

Hb

64.5

5.5

Catalase

Ct

247.5

10-11

Ferritin

Fer

450

11-12

Thyroglobulin

Tg

669

17

2.2.2 Device layout and fabrication
Device design and fabrication are adapted from Hamblin et al.27 Briefly, devices are
fabricated on a 4" Si wafer using UV photolithography, thin metal film deposition, plasma
enhanced chemical vapor deposition (PECVD), and wet and dry etching. Each 4" Si wafer
produces 49 devices; each device has dimensions of 1 cm2 and consists of 200 parallel
nanochannels with height steps. These nanochannels are connected to an injection and waste
reservoir for solution loading and solvent evaporation, respectively, as shown in Figure 2.1. Figure
2.1A shows a top view photograph of a completed device. Figure 2.1B-C shows zoom
photomicrographs of nanochannels, reservoirs, and the height steps. Figure 2.1D-F shows
schematically the relatively simple operational principles of these nanosieving devices.
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Figure 2.1 Overview of device design and operation. (A) Top view photograph of a nanodevice having 1
cm2 dimensions. (B) Magnified photo of channels. (C) Zoom view photo showing height steps and exit
reservoir. (D) Top view schematic showing operation of device including solution injection, flow and
trapping of protein in nanochannels. (E-F) Side view schematics; channel lengths are not drawn to scale.
(E) A ~10 nm protein passes through a 100-15 nm height step and accumulates at the exit. (F) A ~17 nm
protein traps at a 100-15 nm height step.

The device fabrication scheme is shown in Figure 2.2. The following steps are involved in
the fabrication of height step nanodevices. A ~100 nm layer of silicon dioxide is deposited on a
clean 4" Si <100> wafer (Nova Electronic Materials, Flower Mound, TX) using PECVD; then, a
layer of Al is deposited using e-beam evaporation with the thickness equal to the intended height
of the shorter segment (Figure 2.2A). A ~15 nm thick Cr protecting layer is next deposited via ebeam evaporation as shown in Figure 2.2B. Photoresist (AZ nLOF 2020, AZ Electronic Materials,
Branchburg, NJ) is then spun and patterned using photolithography, followed by Cr removal using
chrome mask etchant (OMG Cyantek, Fremont, CA) in preparation for the second layer of Al to
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be deposited to make the taller nanochannel segments (Figure 2.2C). A second layer of Al is
deposited; the sum of the thicknesses of the first and second depositions is equal to the height of
the taller nanochannel segments (Figure 2.2D). After a Cr protective layer is deposited, Al is lifted
off by dissolving the photoresist in N-methyl-2-pyrrolidone (Spectrum, New Brunswick, NJ) at 90
o

C and then the Cr is again removed using chrome mask etchant. AZ 3330 photoresist is next spun

on the wafer and patterned to cover the core nanochannel lines as shown in Figure 2.2E. Exposed
Al is etched in Al etchant (Type A, Transene, Danvers, MA) at 50 oC until Al is removed (~2 min),
followed by photoresist stripping with acetone and 2-propanol (Figure 2.2F). A 4 µm thick capping
layer of SiO2 is next deposited using PECVD to cover the core lines as illustrated in Figure 2.2G.
AZ 3330 photoresist is spun on the substrate and patterned to define injection and waste reservoirs
(Figure 2.2H). Next, exposed oxide is etched completely down to the Si wafer in buffered oxide
etchant (BOE, Transene) to open the channel ends into the reservoirs (Figure 2.2I). Finally, Al
core lines are etched in aqua regia at 130 oC overnight to remove the sacrificial cores and open up
the nanochannels, which are then soaked in deionized water for 4-6 h (Figure 2.2J). I made five
sets of devices, having a height step from 100 nm down to either 15, 18, 19.5, 22 or 29 nm; all
other channel dimensions (length and widths) were held constant.
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Figure 2.2 Fabrication of dual height nanochannels. (A) A ~100 nm thick oxide layer is deposited on a 4”
Si wafer followed by an Al layer. (B) A ~15 nm thick Cr protective layer is deposited. (C) Photoresist is
coated and patterned using photolithography and the exposed Cr is removed. (D) A second Al layer is
deposited to make the tall segment. (E) After depositing a 15 nm Cr protective layer, Al is lifted off and Cr
is removed. Then photoresist is coated and patterned. (F) Exposed Al is removed followed by photoresist
stripping. (G) A capping layer of ~4 µm thick oxide is deposited to cover core lines. (H) Photoresist is
coated and patterned. (I) Exposed oxide is etched to open the ends. (J) Aluminum lines are etched using
aqua regia, and the hollow channels are then filled with water.

I made two important modifications to the previous fabrication method27 to increase
reliability and reproducibility, enabling capillary flow in channels with height steps as small as 15
nm. First, I used a ~15 nm Cr layer to protect the Al layers from the photoresist developer (AZ300
MIF, AZ Electronic Materials) as shown in Figure 2.2B. AZ300 developer slowly etches Al,
resulting in inconsistent height steps, as well as discontinuities in <20 nm height channels.
Secondly, the short segment length and tall segment height were both decreased to ~30 µm and
100 nm, respectively, to reduce the hydraulic resistance difference between these segments. These
improvements enabled fabrication of devices with short segment heights down to 15 nm that
50

sustained capillary flow without any bubble formation. This smaller height range is especially
important because it opens the possibility of separating proteins. In addition, I streamlined several
fabrication steps, such as overnight water and Nanostrip (OMG Cyantek) treatment of
nanochannels, which shortened the fabrication time by ~50%. Step heights were confirmed using
atomic force microscopy (AFM) for all five device types as shown in Figures 2.3 and 2.4. Prior to
trapping experiments, all devices were baked at 110 oC, 170 oC, and then 250 oC, for 15 min at
each temperature. This helped to remove any water that had condensed on the channel surfaces
during storage and also aided in preventing bubble formation during capillary flow. Additionally,
the high temperature bake decreased the number of free surface silanol groups, which could
interact with proteins and cause adsorption.28 My scalable, thin-film fabrication approach provides
for batch processing of ~50 chips per 10-cm-diameter wafer, such that individual devices are
considered to be single use and disposable. However, I note that a Nanostrip soak after trapping
experiments could potentially be implemented to clean out and reuse devices.
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Figure 2.3 AFM measurement of height steps. (A) 15 nm, (B) 18 nm, (C) 19.5 nm, (D) 22 nm, (E) 29 nm,
and (F) 100 nm.

Figure 2.4 Traces of individual height measurements obtained from the corresponding AFM images in
Figure 2.3. (A) 15.3 nm, (B) 17.9 nm, (C) 19.6 nm, (D) 21.6 nm, (E) 29.3 nm, and (F) 100.0 nm.
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2.2.3 Device operation
Nanochannels with height steps can be used to separate proteins based on their size as
illustrated schematically in Figure 2.1D-F. I studied the trapping behavior of five different size
proteins in five different sets of devices to understand the height step and protein size correlation.
Each device design was used to test four different concentrations (0.05, 0.1, 0.5, and 1.0 mg/mL)
of each protein, and each concentration was run on three different devices from the same wafer to
assess reproducibility. For each experiment, 400-500 nL of protein solution was loaded into the
injection reservoir using a 5 µL syringe (Hamilton, Reno, NV), which caused filling of the
nanochannels due to capillary action. Some protein was trapped at the height step, while protein
that made it through the step accumulated at the exit. Solvent evaporation occurred from the
channel ends after capillary flow maintained some additional flow. Each trapping experiment was
run for 1.5 min. I also studied the trapping of Tg and Ct in 100-22 nm devices and Tg in 100-29
nm devices under different buffer ionic strengths (1, 10, 50, and 100 mM). The experimental setup
used to record fluorescence signal included an upright Axio Scope.A1 microscope (Zeiss,
Thornwood, NY) fitted with a 625 mW blue LED light source (470 nm center wavelength,
MBLED, Thorlabs, Newton, NJ). A brightline filter cube (FITC-LP01-Clinical-OMF, Semrock,
Rochester, NY) consisting of a longpass dichroic mirror with a cutoff wavelength of 515 nm was
used to separate excitation and emission signals. Fluorescence was detected using a Photometrics
CoolSNAP HQ2 (Tucson, AZ) cooled CCD camera at 1.67 Hz with a 600 ms exposure time. The
entire detection system was controlled using Micromanager 1.3, an open source, free plug-in to
ImageJ.
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2.2.4 Data analysis
Statistical data analysis was performed on each fluorescence image. I measured the average
fluorescence intensity by drawing the same size region of interest around the fluorescence signal
at the height step and the nanochannel exit, using ImageJ software. For each image, backgroundsubtracted intensity measurements were made on nine nanochannels. The same size region of
interest was used for all nine channels in an image. The region of interest width was kept constant
at 30 pixels (~20 µm), while the region of interest length was set to encompass the longest
fluorescence signal in each image (25 to 40 pixels). Then the ratio of fluorescence intensity at the
height step (trapped, T) divided by the sum of the signals from the height step and exit (total, t)
was measured (T/t) for each channel. From the triplicate data sets for each concentration, an
average T/t ratio and pooled standard deviation were calculated. Triplicate data analysis also
helped in assessing the reproducibility between devices obtained from the same wafer.
2.3 RESULTS AND DISCUSSION
The effect of protein size and concentration on trapping behavior was explored using five
different size proteins and five different height step devices. This correlation study provides useful
insight into the trapping behavior of biomolecules in the 5-20 nm size range at the nanosize
openings, and can serve as a guide to devise nanofluidic devices for separating two or more
proteins of different sizes.
2.3.1 Trapping patterns of different proteins in devices with the same height step
The five proteins are trapped with different ratios in devices with the same height step due
to their different sizes and shapes. Figure 2.5 shows representative fluorescence images of the five
proteins after loading at 0.1 mg/mL in devices with height steps from 100-15 nm. Figure 2.5A
54

shows that the smallest protein (Mb) traversed the entire length of the nanochannels with minimal
stoppage at the height step and significant accumulation at the exit. Figure 2.5B shows that Hb
also largely passed through the height step, although a small proportion of the total Hb was trapped.
Increasing amounts of Ct and Fer were trapped at the height step, and decreasing amounts passed
through to the exit for these larger proteins as seen in Figure 2.5C-D. Finally, the largest protein
(Tg) was almost completely trapped at the height step as shown in Figure 2.5E, with very little
passing through to the exit. Overall, trapping at the 15 nm height step increased as the size of
protein increased, even though the height step was larger than the protein diameter for all except
Tg.

Figure 2.5 Images showing protein trapping at a height step of 100-15 nm as protein diameter increases
from (A-E). All protein concentrations are 0.1 mg/mL. (A) Mb, (B) Hb, (C) Ct, (D) Fer, and (E) Tg.

2.3.2 Trapping patterns of the same protein in devices with different height steps
I also investigated the effect of changing the height step on trapping behavior of a given
protein. Figure 2.6 shows fluorescence images taken for trapping of Tg (0.1 mg/mL) in five
different height step devices. In the 15 nm step devices (Figure 2.6A), Tg was almost completely
stopped at the height step. In devices with 18 nm and 19.5 nm steps, some Tg reached the ends of
the channels while some was trapped at the height steps as shown in Figure 2.6B-C. In
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nanochannels with 22 nm and 29 nm height steps (Figure 2.6D-E), Tg largely passed through to
the end of the channels. A clear change in trapping behavior is observed as the height step goes
from smaller than the protein diameter to considerably larger than the diameter.

Figure 2.6 Images showing a change in trapping pattern of Tg as height step is increased. (A) 15 nm, (B)
18 nm, (C) 19.5 nm, (D) 22 nm, and (E) 29 nm.

2.3.3 T/t ratio as a function of protein concentration
Average T/t ratios obtained for all five proteins in five height step devices were plotted as
a function of protein concentration as shown in Figure 2.7. These data show that trapping behavior
of the proteins was largely independent of concentration, except in a few instances for Hb, Ct and
Tg, usually at the highest concentration (1 mg/mL). This could be a function of a particular
protein's propensity to stick to itself or to the channel surface. Alternatively, concentrationdependent trapping could also possibly be explained by the "keystone effect" (Figure 2.8), wherein
a group of particles acts as a single larger particle that can block the passage of individual
particles.29-30 The formation of a "keystone" will depend on various factors such as protein size,
concentration, and interactions with the walls or other proteins. Although the overall effect of
concentration on the T/t ratio was relatively modest, to avoid this complicating factor, it may be
best to operate devices at or below concentrations of 0.5 mg/mL. Alternatively, my colleague has
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previously shown that clogging at height steps can be addressed by applying an oscillating voltage
along the channels.30
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Figure 2.7 Plots of variation of trapped/total ratio with protein concentration in (A) 100-15 nm, (B) 10018 nm, (C) 100-19.5 nm, (D) 100-22 nm, and (E) 100-29 nm devices. 1 mg/mL data are not shown in (E)
because the length of the plug of fluorescent material that accumulated at the exit extended back beyond
the height step. The error bars indicate plus or minus one standard deviation of the mean.
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Figure 2.8 Schematic showing concentration dependent trapping of a protein smaller than a height step.
(A) At low concentration, most proteins pass. (B) At medium concentration, some proteins stop and some
pass. (C) At high concentration, more proteins are trapped.

2.3.4 T/t ratio versus protein size
The T/t ratio for different step heights was plotted against protein size as shown in Figure
2.9. Figure 2.9A shows that the T/t ratio followed a general upward trend as protein size increased
from 3.5 nm to 17 nm in 100-15 nm devices. In Figure 2.9B, the smaller proteins (Mb and Hb)
show a low T/t ratio for 100-18 nm height steps, and higher T/t ratios were observed for Ct, Fer
and Tg. Figure 2.9C shows a similar trend to Figure 2.9B for trapping as a function of protein size.
In Figure 2.9D the T/t ratio is low for all data points except for 1 mg/mL Tg. Finally, Figure 2.9E
shows a T/t ratio that is independent of protein size in 100-29 nm devices, as approximately the
same (low) T/t ratio was obtained for all protein sizes and concentrations. Importantly, a clear
protein size dependent change in trapping is observed as the height step is altered. This height step
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and protein size correlation demonstrates that size-specific protein trapping can be accomplished
in these nanofluidic systems. Moreover, this correlation study provides valuable information for
developing and evaluating a model to predict the trapping of proteins at different height steps as
described below.
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Figure 2.9 Plots of variation of trapped/total ratio with protein diameter in (A) 100-15 nm, (B) 100-18 nm,
(C) 100-19.5 nm, (D) 100-22 nm, and (E) 100-29 nm devices. The solid lines plot the predicted T/t ratio as
a function of protein diameter, as derived in equation (2.11). The error bars indicate plus or minus one
standard deviation of the mean.
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2.3.5 Trapping model
A model was derived to predict the trapping of a rigid spherical particle at a nanoscale
height step, leveraging an earlier study by Giddings et al.31 on the equilibrium distribution of rigid
spheres in a porous network. An equilibrium partition constant, K, across both sides of an opening
for a rigid spherical particle approaching a gap between two parallel plates can be given as
K=

Aavailable
Apore

(2.1)

where Aavailable is the area available to the particle inside the pore, and Apore is the overall area of
the pore. For a slit opening and a spherical particle,
Apore = WH

(2.2)

Aavailable = W(H − D)

(2.3)

where W is the slit opening width and H is the height of the slit.

where D is the particle diameter. Substituting (2.3) and (2.2) into (2.1) yields
D

K= 1−H

(2.4)

These equations apply to a slit geometry; however, my devices have a step, rather than a slit
geometry (a slit has a step from both the top and bottom surfaces). For the step model Apore is
further reduced because the bottom wall constrains the lower position of the particle on either side
of the height step (see Figure 2.1E-F), effectively reducing the pore height by the radius of the
particle. Therefore, the effective area of the pore for a step geometry is given by
Apore = (H − D⁄2)W

(2.5)
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Combining equations (2.1), (2.3) and (2.5) yields the partition constant for a nanochannel with a
height step,
K=

H−D
H−D⁄2

(2.6)

Now, the particle partitioning at the nanoscale opening can be viewed having an entropic energy
barrier (Eb) given as
(2.7)

Eb = −k B Tln(K)

where kB is the Boltzmann constant and T is the temperature in Kelvin.
The probability for a particle to pass the barrier (Pp) can be given as
Pp =

Passed particles

K=

Passed particles

Total particles

Substituting equation (2.7) into equation (2.8) yields

The trapped particles (T) are given by

= e

−Eb
kB T

Total particles

T = 1 − Passed particles

(2.8)

(2.9)

(2.10)

Finally, substituting equations (2.6) and (2.10) into equation (2.9) yields
T
t

=

D⁄2
H−D⁄2

(2.11)

Equation (2.11) gives a theoretical prediction of the correlation between the fraction of trapped
particles and particle size (for a given step height). This model can be used to predict the trapping
of spherical particles in my nanosieving devices if H and D are known, as they are for these devices
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and proteins. Moreover, the measured T/t ratio can be used to determine D for an unknown
nanostructure for a given height step. I plotted equation (2.11) along with my experimental data in
Figure 2.9. This model fits quite well with the results obtained in my nanosieving systems for
smaller height steps (15-20 nm), with somewhat greater deviations at larger height steps (22 and
29 nm). There are several possible reasons for the observed differences between theoretical and
experimental data. The proteins used in these experiments are not exactly spherical and are
somewhat deformable compared to rigid spheres. There is also some interaction among protein
molecules, and between proteins and the channel walls, which could affect protein trapping.
Finally, unlike with Giddings' theory, in our experiments the proteins have a directional velocity
component towards the nanosieve opening due to capillary flow, which should increase the chance
of a protein passing through the opening, compared to diffusion alone. I also note that flow eddies
that might form at the height steps are not a significant source of protein trapping at height steps
in my devices.
2.3.6 Buffer ionic strength effect on protein trapping
Altered trapping behavior of proteins in nanosieving devices was observed when buffer
ionic strength was changed, resulting in a modified EDL thickness. The EDL is inversely related
to the ionic strength and influences the effective cross-sectional area of a channel. In Figure 2.10,
the trapping results for Tg in different buffer ionic strengths in 100-22 nm height step channels are
shown. Almost all Tg was trapped at the 22 nm height step for 1 and 10 mM ionic strength (Figure
2.10A-B). At 50 mM ionic strength, Tg equally distributed at the height step and exit (Figure
2.10C). However, Figure 2.10D shows that most of the Tg passed through the 22 nm height step
on increasing the ionic strength to 100 mM. Overall, the amount of Tg passing through the height
step increased as buffer ionic strength was changed from 1 to 100 mM. Similarly, Ct and Tg were
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tested in height step devices and average T/t fluorescence ratios were plotted as a function of buffer
ionic strength (Figure 2.11). A decrease in T/t ratios was observed as the buffer ionic strength was
increased, resulting from the reduced EDL thickness. Figure 2.11B shows that the T/t ratio for Tg
in a 100-29 nm device decreased compared to in the 100-22 nm device in Figure 2.11A. In Figure
2.11A, the Tg size is only 23% smaller than the 22 nm height step; therefore, Tg was trapped even
at the highest buffer ionic strength. On the other hand, in Figure 2.11B, the Tg size is 41% smaller
than the 29 nm height step, and most of Tg passed to the exit on increasing buffer ionic strength
above 50 mM, although a slight increase in T/t ratio was observed when ionic strength was changed
from 50 to 100 mM. This unexpected behavior could result from variability in nanochannel height.
Furthermore, Ct showed lower T/t ratios in Figure 2.11C than Tg in Figure 2.11A because the 22
nm height step is more than double the diameter of Ct. In summary, protein flow through a height
step in a nanochannel is dependent on buffer ionic strength. Buffer ionic strength effects on protein
trapping can be avoided by using high buffer ionic strengths, as EDL thickness decreases below 1
nm above 100 mM ionic strength.

Figure 2.10 Fluorescence images showing the trapping of 0.5 mg/mL Tg in (A) 1 mM, (B) 10 mM, (C) 50
mM, and (D) 100 mM ionic strength buffer, in 100-22 nm height step devices.
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Figure 2.11 Plots of variation of T/t ratios with buffer ionic strength. (A) Tg trapping in 100-22 nm height
step devices. (B) Tg trapping in 100-29 nm height step devices. (C) Ct trapping in 100-22 nm height step
devices.
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3.

INCREASING

PROTEIN

SIGNAL

USING

HEAT-TREATED

THIN-FILM

MICROFABRICATED NANOCHANNELS
3.1 INTRODUCTION
Proteins are biological macromolecules involved in many physiological functions, and are
formed by the bio-polymerization of amino acids.1 Amino acids define the biological, physical and
chemical properties of proteins.2-3 For example, protein surface charges are the result of amino
acid functional groups. In protein analysis, adsorption on surfaces is a common problem. Protein
adsorption in nanofluidics leads to loss of analyte for detection, changes in surface properties, and
potentially blockage at the channel entrance through the “keystone effect” described in Section
2.3.3,4 all of which result in lower protein signal. There are four fundamental mechanisms of
protein interaction with surfaces: ionic or electrostatic interaction, hydrogen bonding, hydrophobic
interaction, and charge-transfer or donor/acceptor interactions.5 Electrostatic interaction of
charged amino acid residues in proteins6-7 can cause adsorption and create problems in protein
analysis.
In Chapter 2, silica-based nanochannels were used to study the correlation between protein
size and ability to pass through channel constrictions. Silica surfaces have silanol (Si‒OH) groups
on the surface (4.6 groups/nm2)8 which are weakly acidic (pKa 4.5).9 At pH values above 4, these
silanol groups are deprotonated to silanoate groups (Si‒O-). This negatively charged silica surface
can interact electrostatically with positively charged (basic) proteins which results in their
adsorption.10-11 On a silica surface, adjacent silanol groups can fuse together through a dehydration
reaction to form siloxane (Si-O-Si) bridges, resulting in a reduced surface density of silanol groups.
Temperature plays an important role in the conversion of surface silanol groups to siloxanes.8 The
number of surface silanol groups can be reduced to half or none by heating under vacuum to 400
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C or 1200 oC, respectively. However, silanol groups reform when a silica surface contacts

moisture or aqueous solution. Silanol groups also render silica surfaces hydrophilic, which is
important in the filling of nanochannels by capillary action. Therefore, partial elimination of
silanol groups can minimize protein adsorption while maintaining surface hydrophilicity.
Electrostatic adsorption of proteins can be reduced by acid/base treatment or surface
coating. For example, a silica surface can be rendered completely charge free by decreasing the
solution pH below 2. However, in my method, low pH is not desirable because fluorescence on
the labeled proteins is quenched. There are additional procedures available which can be used to
reduce protein adsorption, such as dynamic or permanent surface coating.12-13 Poly(ethylene
glycol) is an example of a coating polymer used to minimized protein adsorption on oxide
surfaces.11 For my size-based analysis of proteins in nanochannels, the use of buffer additives can
alter the protein structure, which could change trapping behavior at nanochannel height steps,
block nanochannels, or decrease experimental reproducibility.
Protein adsorption remains a problem for nanofluidic systems, because current methods to
reduce non-specific adsorption are complicated or lack reproducibility. In this chapter, a new
method to reduce protein adsorption by heating devices with nanochannels to 250 oC is described.
This method removes surface-adsorbed water molecules and reduces the surface silanol group
density through dehydration to siloxane bridges. This concept is first studied with hemoglobin in
heat-treated and untreated 100-15 nm height step devices. The reduction in protein adsorption is
observed through an increase in the intensity of protein signal at channel exits. Because Ta2O5 has
similar surface chemistry to silica,14-15 nanochannels made in Ta2O5 are also tested for the effects
of heat treatment on protein signal.
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3.2 MATERIALS
Hemoglobin (Hb) and catalase (Ct) from Sigma-Aldrich (St. Louis, MO), see Table 2.1,
were labeled with fluorescein isothiocyanate (FITC, Invitrogen, Eugene, OR) and processed as
described in Chapter 2.2.1. The final stock concentration of processed protein solution was
measured using a Nanodrop spectrophotometer (ND-1000, Wilmington, DE), and solutions were
stored at 4 oC until used. Before experiments, each protein solution was vortexed and
volumetrically diluted to 0.5 mg/mL in 100 mM Tris-HCl buffer (pH 8.3), containing 1 mM
sodium dodecyl sulfate (Shelton Scientific, Peosta, IA) and 0.12% v/v Triton X-100 (SigmaAldrich) as surfactants.
3.3 EXPERIMENTAL
3.3.1 Single-height Ta2O5 and SiO2 nanochannel fabrication
The 100 nm tall nanochannels were fabricated to study the effect of heat treatment on
protein signal. The fabrication recipe was adapted from the one described in Section 2.2.2, and
involved use of UV photolithography, thin metal film deposition, plasma enhanced chemical vapor
deposition (PECVD), and wet and dry etching to make single-height nanochannel devices on a 4”
Si wafer. SiO2 and Ta2O5 were used to form the nanochannel walls. Figure 3.1 shows single-height
Ta2O5 nanochannel fabrication steps. A ~100 nm layer of Ta2O5 was sputtered on a clean 4" Si
<100> wafer (Nova Electronic Materials, Flower Mound, TX) using a Denton sputtering system
(Denton Vacuum, Moorestown, NJ); then, a ~100 nm layer of Al was deposited using e-beam
evaporation to define the nanochannel height (Figure 3.1A). Photoresist (AZ 3330, AZ Electronic
Materials, Branchburg, NJ) was spun on to make a uniform layer on Al (Figure 3.1B). Photoresist
was patterned using UV photolithography to define the nanochannel core lines (Figure 3.1C).
Exposed Al was etched in Al etchant (Type A, Transene, Danvers, MA) at 50 oC until Al was
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removed (~2 min), and then photoresist was dissolved in acetone and 2-propanol (Figure 3.1D).
Al core lines were covered with ~500 nm of sputtered Ta2O5 to form the side walls and tops of the
nanochannels (Figure 3.1E). A 3-µm-thick capping layer of SiO2 was next deposited on the Ta2O5
using PECVD, followed by evaporation of ~300-nm-thick Cr and patterning of AZ 3330
photoresist to define injection and exit reservoirs as illustrated in Figure 3.1F. Exposed Cr was
removed using Cr etchant (OMG Cyantek, Fremont, CA), and the uncovered SiO2/Ta2O5 layer
was anisotropically etched down to Si in a CF4/O2 plasma using a Trion RIE/ICP etcher (Trion
Technology, Clearwater, FL). This resulted in exposure of channel ends in the reservoirs (Figure
3.1G). After that, the remaining Cr was removed using Cr etchant. Al core lines were etched in
aqua regia at 130 oC overnight to remove the sacrificial cores and open up the nanochannels, which
were then soaked in deionized water for 4-6 h (Figure 3.1H). Finally, the hollow nanochannels
were treated with Nanostrip (OMG Cyantek) overnight at 90 oC, followed by an overnight soak in
deionized water. Then, devices were removed from the water and baked at 80 and 120 oC for 10
min each, and stored in a Petri dish. SiO2 nanochannels were also fabricated, largely following the
same procedure but with the following changes. First, the Ta2O5 layers in Figure 3.1 were replaced
with PECVD-deposited SiO2; also, Cr deposition and removal steps were omitted in Figure 3.1FG. Finally, the SiO2 layer was etched isotropically in buffered oxide etchant (Transene) to make
injection and waste reservoirs in Figure 3.1G. I also fabricated 100-15 nm height-step channels as
described in Chapter 2.2.2 for use in preliminary experiments.
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Figure 3.1 Fabrication scheme for single-height Ta2O5 nanochannels. (A) 100 nm of Ta2O5 is sputtered on
a Si wafer and then 100 nm of Al is evaporated. (B) Photoresist is spun on. (C) Photoresist is patterned
using photolithography. (D) Al is etched, followed by resist stripping. (E) 500 nm of Ta2O5 is sputtered. (F)
3 µm of SiO2 is deposited, followed by evaporation of 300 nm of Cr. Then, photoresist is patterned. (G)
Exposed Cr is etched, and next the deprotected SiO2 is etched in a plasma. Then, photoresist and Cr are
removed. (H) Al cores are etched in aqua regia, and empty channels are treated with Nanostrip.

3.3.2 Device operation and data analysis
Devices are baked on a hot plate at 130 and 210 oC for 30 min at each temperature and then
at 250 oC for 30 to 60 min before use. Device operation is described in Chapter 2.2.3. Briefly,
protein solution loaded in the injection reservoir flows into the nanochannels due to capillary
action, and further flow is maintained by solvent evaporation from the channel ends. In this
chapter, single-height nanochannels are used; therefore, proteins only accumulate at the channel
exit in these devices. The performance of untreated and heat-treated SiO2 and Ta2O5 nanochannels
is evaluated in terms of the increase in protein signal at the channel exit. Each trapping experiment
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involves loading of 500 nL of a 0.5 mg/mL solution of Hb or Ct into the injection reservoir using
a 5 µL syringe (Hamilton, Reno, NV), and recording 60 s of CCD data of protein accumulation at
the exit of eleven nanochannels. The hardware and software setup used in these experiments is the
same as described in Chapter 2.2.3. Trapping experiments are performed in both heat-treated and
untreated devices. The “measure hyperstack” free plug-in to ImageJ software (National Institutes
of Health, Bethesda, MD) is used to measure the fluorescence intensity of accumulated protein at
the channel exit from 0 to 60 s. For each video recording, a box (40x90 pixels2) is drawn at the
end of nine channels to encompass a region of interest showing maximum fluorescence signal to
measure the average fluorescence intensity. For each experiment, the average fluorescence
intensity and standard deviation from nine channels are calculated over 60 s to assess variability
among nanochannels on the same device.
3.4 RESULTS AND DISCUSSION
Figure 3.2 shows initial data obtained on trapping behavior of Hb in untreated and heattreated 100-15 nm height-step devices. A weak fluorescent signal at the exit of untreated channels
was obtained 90 s after injection of Hb solution. On the other hand, a ~6x increase in Hb
fluorescent signal at the exit was observed when nanosieving devices were treated with heat before
use as described in Chapter 2.2.2. I hypothesized that this high-temperature bake helped in
removing adsorbed water molecules from the surface and decreased the number of silanol groups.
This observation led me to further explore the effect of heat treatment on protein signal at the exit
of single-height SiO2 and Ta2O5 nanochannels.
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Figure 3.2 Preliminary data showing increase in Hb fluorescence signal at the exit in 100-15 nm heightstep nanochannels on heat treatment. (A) Images showing the accumulation of 0.05 mg/mL Hb at the
nanochannel exit in (left) untreated, and (right) heat-treated devices. (B) Plot of fluorescence intensity at
the exit over time for the nanochannels in (A).

3.4.1 Increase in protein signal with heat treatment of single-height nanochannels
The effect of heat treatment of SiO2 and Ta2O5 nanochannels on protein signal was
evaluated using two proteins of different sizes, Hb and Ct. Multiple 100-nm-tall Ta2O5 and SiO2
nanochannels were tested, and an increase in Hb and Ct accumulation at the channel exits was
observed after heat treatment, as shown in Figure 3.3. The total amount of each protein reaching
the exit of the nanochannel was greater after heat treatment of nanochannels before use, as shown
by the increase in the fluorescence signal. More protein was observed at the SiO2 channel exits
than at the Ta2O5 channel exits. I attribute this to the fact that the reservoirs in SiO2 devices were
wet etched isotropically, which resulted in channels with larger openings and exits that both
allowed more protein to enter into the channels and resulted in increased evaporation from the
channel exits.
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Figure 3.3 Fluorescence images of accumulated Hb and Ct at the exit in 100-nm-tall SiO2 and Ta2O5
channels. (Left) untreated and (right) heat-treated channels. (A) Hb and (B) Ct in SiO2 channels. (C) Hb
and (D) Ct in Ta2O5 channels.

78

The Ta2O5 devices showed a consistent increase in protein signal at the exit after heat
treatment of nanochannels over eight devices tested. However, the increase in protein signal after
heat treatment was not always observed in SiO2 devices, as shown in Figure 3.4. In this figure, Ct
fluorescence signal was not much different at the exit of untreated and heat-treated nanochannels.
Table 3.1 further shows that the increase in fluorescence signal in heat-treated SiO2 devices was
not significant compared to the signal in untreated SiO2 devices. These results from SiO2 devices
could be attributed to irregularities in the composition of SiO2 deposited using PECVD over time.
Environmental factors such as humidity may be another reason for the behavior seen in SiO2 chips.

Figure 3.4 Images showing accumulation of 0.2 mg/mL Ct at the exit of channels in (left) untreated and
(right) heat-treated SiO2 devices.
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Table 3.1 Average and standard deviation of fluorescence of Hb and Ct at the exit of seven nanochannels
in untreated and heat-treated SiO2 devices.

Protein

Concentration

Average fluorescence signal

(mg/mL)

Untreated

Heat-treated

Hb

0.4

33±2

38±6

Ct

0.4

47±3

48±2

Ct

0.2

31±2

29±1

Figure 3.5 shows average fluorescence intensity measurements of Hb and Ct at the exits of
untreated and heat-treated SiO2 and Ta2O5 channels as a function of time. Heat-treated SiO2
devices showed 3.2x and 2.5x greater signal at the exit for Hb and Ct, respectively. In contrast,
heat treatment of Ta2O5 devices increased the Hb and Ct signal at the channel exits by 24x and
63x, respectively. Small fluctuations in fluorescence intensity in Figure 3.5 were caused by
evaporation of solvent in the injection reservoir, which retracted the meniscus in the channel and
stopped the accumulation of proteins at the exit. Protein accumulation at the exit was recovered
after replenishing the solution in the injection reservoir, seen as an increase in intensity after the
marked dips in Figure 3.5.
Both SiO2 and Ta2O5 surfaces have ‒OH functional groups that can lose a proton in basic
conditions and provide a negatively charged surface. Proteins typically have charges distributed
on their surfaces, which can interact both with other protein molecules and channel surfaces. These
combined interactions could cause sticking of proteins along the nanochannels, as well as at the
channel entrance, both of which would decrease protein signal at the channel exits. When devices
were heated before use, the surface –OH groups condensed to form Si‒O‒Si or Ta‒O‒Ta bridges,
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reducing the surface charge density. This reduction in surface charge should result in decreased
electrostatic interaction between proteins and the dry channel surfaces, leading to more protein
signal at the channel exits, as observed. This effect would occur only when protein hits a dry
channel surface because silanol groups reform on contact with aqueous solutions.
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Figure 3.5 Plots of fluorescent intensity at the exit over time for untreated and heat-treated channels in
Figure 3.3. (A) Hb and (B) Ct in SiO2 channels. (C) Hb and (D) Ct in Ta2O5 channels. Arrows mark times
where solution was added into injection reservoirs.
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4. ASSESSMENT OF OFF-CHIP FLUORESCENT LABELING OF PRETERM BIRTH
BIOMARKERS

AND

SEPARATION USING CAPILLARY AND MICROCHIP

ELECTROPHORESIS
4.1 INTRODUCTION
Analytical chemistry involves separation, identification and quantification of chemical
analytes of natural and artificial origin.1 Biomolecules such as proteins, peptides, nucleic acids and
carbohydrates are examples of chemical analytes of natural origin. Many biomolecules have been
identified whose concentrations can be correlated with health issues. Such biomolecules are called
biomarkers.2-3 For example, there are many cancer biomarkers; carcinoembryonic antigen is used
to screen for colon cancer; and α-fetoprotein, beta human chorionic gonadotropin and lactate
dehydrogenase are monitored in germ cell tumors.4 In addition, neutrophil gelatinase associated
lipocalin, kidney injury molecule-1, monocyte chemotactic peptide, netrin-1, and interleukin-18
are recently found biomarkers for acute kidney injury.5
I am interested in preterm birth (PTB), a pregnancy complication that involves delivery
before 37 weeks of gestation.6 Many neonatal deaths and illnesses are caused by PTB. Recently,
three PTB peptide biomarkers have been found, that complement six previously identified PTB
biomarker proteins (see Table 4.1).7 This panel of nine biomarkers in serum results in high
sensitivity (86.5%) and specificity (80.6%) in predicting a PTB 9 weeks before contractions.
Unfortunately, there is presently no simple clinical method available for early diagnosis of PTB;
hence, therapeutic interventions are often too late to prevent PTB. Importantly, these nine PTB
biomarkers at 28 weeks of pregnancy show promise to be used to predict risk of a subsequent PTB;
with that information, steps can be taken that would help in delaying the delivery.
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Table 4.1 A list of PTB biomarkers.7

Peptide 1

QLGLPGPPDVPDHAAYHPF

Peptide 2

NVHSAGAAGSRMNFRPGVLSSRQLGLPGPPDVPDHAAYHPF

Peptide 3

NVHSAGAAGSRM(O)NFRPGVLSSRQLGLPGPPDVPDHAAYHPF

Proteins

Ferritin, Defensin, Lactoferrin, Thrombin antithrombin, TNF-α receptor type 1,
and Corticotropin-releasing factor

Liquid chromatography-mass spectrometry (LC-MS) is often used for initial identification
of biomarkers,8 but LC-MS has problems with scalability and cost. For example, LC-MS
instruments are bulky and expensive, and cannot be used for point-of-care applications;
additionally, the cost of completing LC-MS analyses can be high. On the other hand, microfluidics
offers a promising platform for routine biomarker analysis, presenting advantages such as
portability, rapidity, and point-of-care capability.9 Microchip electrophoresis (µCE) is a powerful
microfluidic separation method; it involves short analysis time, reduced reagent consumption, and
ease of integration of multiple processes. Such advantages of µCE could allow rapid and sensitive
analysis of PTB biomarkers at low cost.
Laser-induced fluorescence (LIF) is the most common detection method used in µCE.10
Unfortunately, most analytes are not naturally fluorescent; therefore, they need to be derivatized
with fluorophores, for example they covalently react with amine, thiol, aldehyde and other groups
to form a fluorescing complex.11 Alternatively, noncovalent labeling based on hydrophobic or
ionic interactions is also possible.12 The nine PTB biomarkers (Table 4.1) are proteins or peptides
on which lysine residues and the N-terminus provide primary amine sites for fluorescent labeling.
However, there are some challenges in labeling of PTB biomarkers. PTB peptides are difficult to
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label in their native conformation due to unavailability of the N-terminus which may be enclosed
in the peptide 3-D structure.13 Additionally, proteins label slowly (~24 h) and form multiplylabeled isoforms that result in broad µCE peaks that might overlap with closely eluting peaks and
cause problems in quantitative analysis.
In this chapter, the labeling of four PTB biomarkers is assessed using conventional CE and
µCE. Peptide labeling is improved under denaturing conditions that improve access to the Nterminus. Moreover, a narrow ferritin (Fer) fluorescence peak is obtained when it is labeled only
for a short duration (~20 min). Finally, a µCE protocol is developed to separate four PTB
biomarkers, including the three peptides and Fer in less than 3 min. These separation procedures
should be useful in the analysis of PTB biomarkers in integrated devices developed in Chapters 56.
4.2 MATERIALS
Silicon <100> wafers are purchased from Desert Silicon (Tempe, AZ) to prepare templates
for microchannel fabrication, using photolithography and wet etching. PMMA sheets (1.5- and
3.0-mm-thick) for device fabrication are obtained from Cyro Industries (Rockaway, NJ) and cut
into 2”x0.8” pieces using a laser cutter (Universal Laser Systems, Scottsdale, AZ). Peptide 1,
peptide 2, and peptide 3 (see Table 4.1) are custom synthesized by GenScript (Piscataway, NJ).
Fer is obtained from EMD milllipore (Billerica, MA). Sodium borate buffer (100 mM) is prepared
by dissolving 155 mg of boric acid in deionized (DI) water and adjusting the pH to 10.1 with 6 M
NaOH solution. Borate buffer is diluted to 20 mM, and 20 mM NaCl and 0.2% w/w
hydroxypropylcellulose (HPC, Sigma-Aldrich, St. Louis, MO) are added for µCE. Fluorescein
isothiocyanate (FITC) and Alexa Fluor 488 5-tetrafluorophenyl ester (ALF) are obtained from Life
Technologies (Carlsbad, CA) for fluorescent labeling of peptides and Fer. Dimethyl sulfoxide
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(DMSO) used in preparation of the fluorescent label stock and peptide denaturation is obtained
from Sigma-Aldrich. All solutions are prepared in purified DI water filtered through a Barnstead
Nanopure System (Thermo Scientific, Waltham, MA).
4.3 EXPERIMENTAL
4.3.1 PMMA device fabrication
A master mold is fabricated on a 4” Si wafer using photolithography and wet etching as
shown in Figure 4.1. First, the Si wafer is oxidized in a Bruce tube furnace (Bruce Industrial
Controls, New Castle, DE) to grow 500-600 nm of oxide. The oxidized Si wafer is cleaned with
acetone and 2-propanol (IPA), and dried with N2. The cleaned oxidized wafer is baked in an UltraClean 100 Oven (Lab-Line, Dubuque, IA) at 150 oC for 15-20 min. The cleaned Si wafer is primed
with hexamethyldisilazane (HMDS, SPI, West Chester, PA) followed by spin coating of
photoresist (S1805, Rohm and Haas, Marlborough, MA). The photoresist-coated wafer is baked at
110 oC for 1 min and exposed to UV light through a Cr mask. The exposed Si wafer is baked at
110 oC for 5 min and developed in MF-26A developer (Rohm and Haas) for ~2 min until clear
features are formed. The developed wafer is baked at 110 oC for 5 min to improve resist adhesion
to the wafer and cleaned in an O2 plasma (Planar Etch II, Technics, San Jose, CA) for 1 min at 150
W. Then, the unprotected oxide is etched in buffered oxide etchant (BOE, Transene, Danvers, MA)
for 8-10 min until the SiO2 is completely etched down to the Si surface. Next, photoresist is rinsed
off using acetone and IPA. The Si wafer is diced into individual device templates using a diamond
cutter. Diced templates are wet etched in 40% aqueous KOH solution at 70 oC to make 18-20 µm
tall features.
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Figure 4.1 Schematic showing Si template fabrication.

Next, enclosed microchannels are made in PMMA as shown in Figure 4.2. Microchannel
fabrication involves three steps: hot embossing, laser cutting, and thermal bonding. Patterns from
the Si template are transferred into 1-mm-thick PMMA by hot embossing at 138 oC for 26 min in
a precision convection oven (Thermo Scientific, Asheville, NC). Reservoir holes are laser cut in
3-mm-thick PMMA, and the plate is flattened at 110 oC for 20 min to smooth reservoir edges.
Later, the flattened and imprinted PMMA pieces are aligned together and thermally bonded at 110
o

C for 23-25 min. Finally, the bonded PMMA edges are sealed chemically using acetonitrile, and

DI water is flowed to test the channels.
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Figure 4.2 Schematic showing fabrication of PMMA microfluidic devices. (A) Hot embossing to imprint
Si features on PMMA. (B) Thermal bonding to enclose microfluidic channels within the PMMA.

4.3.2 Off-chip labeling protocol
Fer is labeled with FITC as described in Chapter 2.2.1. Various additional labeling
conditions were attempted for labeling PTB peptides since labeling is inefficient under the
conditions used for Fer. FITC and ALF (structures shown in Figure 4.3) were used for peptide
labeling with stock solutions prepared in DMSO. Fluorescent labeling conditions for all three
peptides and the various parameters are given in Table 4.2. After labeling, all peptide samples were
diluted in borate running buffer for conventional CE analysis. For µCE, only denatured solution
of peptides 2 and 3 were filtered using a 2 kDa mass cutoff membrane filter (Millipore, Billerica,
MA) in a microcentrifuge to remove excess dye. Microchip CE samples were diluted in 5 mM
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borate (pH 10.1), containing 20 mM NaCl and 0.2% w/w HPC. Since a membrane filter smaller
than 2 kDa mass cutoff is not available commercially, synthesized fluorescently labeled peptide 1
was used for µCE.
Table 4.2 PTB peptide labeling conditions.

Experiment Peptide
conc.
Peptide 1-

Dye conc.
ALF

3 mM

FITC

Denaturing
conditions

pH 10.65, 4 h @37 oC,

0.5 mM

then overnight @4 oC

native
Peptide 1-

3 mM

2.5 mM

denatured
Peptide 2-

10% v/v DMSO +

pH 9.65, 7 h @37 oC, then

5 min @95 oC

overnight @RT*
pH 10.65, 4 h @37 oC,

0.8 mM 0.3 mM

then overnight @RT*

native
Peptide 2-

1.2 mM

1.1 mM

denatured
Peptide 3-

10% v/v DMSO +

pH 9.65, 7 h @37 oC, then

5 min @95 oC

overnight @RT*
pH 10.65, 4 h @37 oC,

1.9 mM 0.4 mM

then overnight @4 oC

native A
Peptide 3-

1.4 mM

pH 10.65, 5 h @37 oC,

1.3 mM

then overnight @RT*

native B
Peptide 3-

Labeling conditions†

1.9 mM

1.8 mM

2.1 mM

2 mM

pH 9.65, overnight @37 oC

native C
Peptide 3denatured

10% v/v DMSO +

pH 9.65, 5 h @37 oC, then

6 min @75 oC

overnight @RT*

† In all labeling 100 mM BCB was used. * RT: room temperature.
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Figure 4.3 Fluorescent dye structures. (A) FITC and (B) ALF.

4.3.3 PMMA device layout and operation
Microchip electrophoretic separation of PTB biomarkers is performed in an offset “T”
device fabricated in PMMA; a schematic is shown in Figure 4.4A.14 Three different mixtures of
PTB biomarkers are analyzed: Fer (10 nM) and peptide 3 (200 nM); Fer (9 nM), peptide 1 (125
nM) and peptide 3 (165 nM); and Fer (11 nM), peptide 1 (150 nM) and peptide 2 (150 nM). Each
device consists of four reservoirs: sample, sample waste, running buffer, and separation waste (see
Figure 4.4A). Microchip CE operation involves three steps: sample injection, plug formation, and
electrophoretic separation. In this study, pinched injection is used to form the sample plug at the
channel intersection.15 Briefly, a small sample volume (~20 µL) is added in the sample reservoir,
and separation buffer (20 mM borate, pH 10.1, 0.2% HPC, 20 mM NaCl) is loaded in the remaining
3 reservoirs. Then, 600 V is applied at the sample waste reservoir, while keeping the other
reservoirs at ground, as shown in Figure 4.4B. This moves the negatively charged sample from the
sample reservoir toward the sample waste reservoir. After ~1 min, the voltages are reconfigured
(see Figure 4.4C): a small pull-back voltage (600 V) is applied to the sample and sample waste
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reservoirs to pull back sample, a high voltage (1500 V) is applied at the separation waste reservoir,
and the running buffer reservoir is maintained at ground. This results in the injection of the sample
plug at the intersection, which leads to separation based on electrophoretic mobility as analytes go
down the separation channel, as shown in Figure 4.4D. Separated analyte bands are detected using
an LIF detection system, consisting of an inverted Eclipse TE 300 microscope (Nikon, Melville,
NY), 488 nm diode laser (JDSU, Shenzhen, China), photomultiplier tube (PMT, Hamamatsu,
Japan), low-noise preamplifier (Stanford Research Systems, Sunnyvale, CA) and custom-made
voltage switching box. Data are acquired using a custom LabVIEW program. LIF detection system
parameters include a PMT setting of 860 V, signal amplification of 2x, and a detection distance
2.6 cm past the intersection.

Figure 4.4 Schematic showing operation of an offset “T” µCE device. (A) Device layout. (B) Sample is
injected through the intersection, and then the voltages are reconfigured, leading to (C) sample plug
formation, and over time (D) electrophoretic separation.
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4.3.4 Evaluation of ferritin labeling
Off-chip, time-dependent labeling of Fer with FITC and ALF is evaluated using µCE. A 500 nM
Fer solution is prepared in 10 mM BCB (pH 9.8), and FITC or ALF is added to the solution at a
molar ratio of 20:1. The protein-dye mixture is incubated either for 20 min or overnight at room
temperature to evaluate the degree of labeling. Next, excess dye is removed using a 30 kDa cutoff
membrane filter. To avoid sample loss, a maximum of two centrifugal filtrations are done. Fer
stock solution concentration is measured using a Nanodrop spectrophotometer (ND-1000,
Wilmington, DE) and reconstituted to 500 nM in 10 mM BCB (pH 9.8). Labeled Fer samples are
separated using µCE. Microchip separation buffer is 20 mM BCB, pH 11, 20 mM NaCl, and 0.2%
HPC. Sample is injected for 45 s as described in Section 4.3.3, but using 400 V and separation is
performed using 1000 V. LIF is detected 1.5 cm from the intersection using a PMT setting of 970
V with 2x amplification.
4.3.5 Capillary electrophoresis separation
A P/ACE MDQ capillary electrophoresis system (Beckman Coulter, Pasadena, CA) is used
to analyze off-chip labeled PTB biomarkers. The CE system is equipped with a diode array UV/Vis
detector and 57-cm-long fused silica capillary with a 75 µm internal diameter and 50 cm effective
separation length. All samples are prepared in CE running buffer and injected for 0.5 s using 0.5
psi. Most separations are in 50 mM borate buffer (pH 10.3) at 25.0 kV; any exceptions are noted
in the figure captions.
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4.4 RESULTS AND DISCUSSION
PTB biomarkers for microchip and conventional CE were labeled off-chip, enabling LIF
detection during µCE. Fer has multiple labeling sites and is easy to fluorescently label with the
procedure described in Chapter 2.2.1. Conversely, PTB peptides have only one primary amine
labeling site (on the N-terminus), which made labeling problematic under conventional conditions.
Therefore, multiple procedures were tried and labeling was assessed using benchtop CE.
Figures 4.5A-B show CE separations of fluorescent dyes (FITC and ALF) and unlabeled
peptide 3, respectively. Dye peaks were symmetrical, but unlabeled peptide 3 peak had a little
fronting. I compared peak heights of labeled and unlabeled peptides in all CE plots to evaluate the
degree of labeling. In Figure 4.5C-D (native A and B), peptide 3 was not labeled efficiently with
either ALF or FITC, but FITC labeling was better than with ALF. ALF is larger than FITC (see
Figure 4.3), which could possibly cause steric hindrance to access the N-terminus. Therefore, FITC
labeling was further evaluated. The extent of peptide 3 labeling was improved somewhat in
comparison to Figure 4.5D by a longer time at 37 oC as shown in Figure 4.5E, since reaction
kinetics increase with temperature. Moreover, a further improvement in labeling was observed as
compared to Figure 4.5E when peptide 3 was denatured before labeling (see Figure 4.5F).
Denatured peptide 3 should open up access to the N-terminus for labeling. All peaks in the CE
plots were baseline resolved; however, peptide peaks showed a little fronting except in Figure
4.5C.
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Figure 4.5 CE separation of peptide 3 labeled with ALF and FITC under different conditions. (A) FITC
(500 µM) and ALF (3.4 µM). Separation in 50 mM borate buffer, pH 10.5, 22.0 kV. (B) Unlabeled peptide
3 (50 µM). (C) Peptide 3-native A (58.0 µM). Separation in 50 mM borate buffer, pH 10.5, 22.0 kV. (D)
Peptide 3-native B (50 µM), 50 mM borate buffer, pH 10.5, 20.0 kV. (E) Peptide 3-native C (50 µM). (F)
Peptide 3-denatured (50 µM). Labeling conditions are in Table 4.2.

Peptide 2 labeling was also evaluated using conventional CE as shown in Figure 4.6.
Figures 4.6A-B show CE separations of fluorescent dyes (FITC and ALF) and unlabeled peptide
2, respectively. Dye peaks were symmetrical, but the unlabeled peptide 2 peak had a little fronting
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and an apparent unresolved impurity peak. Under native labeling conditions, the labeled peptide 2
peak height was lower than that of the remaining unlabeled peptide 2 after reaction, as seen in
Figure 4.6C. Here, all peaks were resolved and symmetrical. When peptide 2 was denatured before
labeling, an increase in the labeled peptide 2 peak height compared to the unlabeled one was
observed as shown in Figure 4.6D, indicating that as with peptide 3, labeling efficiency is improved
with denaturation. In Figure 4.6D, unlabeled and labeled peptide 2 peaks showed tailing and
fronting, respectively.

Figure 4.6 CE separation of peptide 2 labeled with ALF and FITC under different conditions. (A) FITC
(500 µM) and ALF 488 (4.5 µM). Separation in 50 mM borate buffer, pH 10.5, 25.0 kV. (B) Unlabeled
peptide 2 (70 µM). (C) Peptide 2-native (50 µM). Separation in 50 mM borate buffer, pH 10.5, 25.0 kV.
(D) Peptide 2-denatured (23 µM). Labeling conditions are in Table 4.2.

Finally, peptide 1 was labeled with FITC and separated using CE as shown in Figure 4.7.
Figures 4.7A-B show CE separations of FITC and unlabeled peptide 1, respectively; both the peaks
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were symmetrical. In Figure 4.7C, the degree of peptide 1 labeling was low under native
conditions; moreover, the unlabeled and labeled peptide 1 peaks showed tailing and fronting,
respectively. As with peptides 2-3, peptide 1 labeling was improved significantly (see Figure 4.7D)
on denaturing before labeling, and a symmetrical peak was formed in the CE run.

Figure 4.7 CE separation of peptide 1 labeled with FITC under different conditions. (A) FITC (500 µM).
(B) Unlabeled peptide 1 (50 µM). (C) Peptide 1-native (100 µM). Separation in 50 mM borate buffer, pH
10.5, 25.0 kV. (D) Peptide 1-denatured (60 µM). Labeling conditions are in Table 4.2.

Differences in migration times of peptides and dyes resulted from different CE conditions
described in the figure captions. Furthermore, ALF- and FITC-labeled peptide migration was
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different under similar CE conditions because of their different charge-to-mass ratios. For all three
peptides, the labeling was improved when they were denatured before labeling. Among the
peptides, peptide 1 showed the best labeling, most likely because it is shorter than peptides 2 and
3, so the N-terminus is more accessible.
On-chip protein labeling for PTB analysis in an integrated device may need to be done with
low protein concentrations (~1 µM) in low ionic strength (10 mM) buffers with short (~20 min)
reaction times. I tested conventional off-chip labeling conditions, including ones that might be
used for on-chip labeling. Both ALF and FITC were tested; protein-dye mixtures were incubated
for 20 min and overnight at room temperature. Labeled Fer samples were separated by µCE as
shown in Figure 4.8. Fer was labeled to approximately the same degree in 20 min with ALF and
FITC in Figure 4.8A. In contrast, Fer was labeled better with ALF over FITC in overnight labeling
in Figure 4.8B; however, the Fer peaks were broader compared to 20 min labeling. Fer is a large
(450 kDa) protein and has thirteen lysine residues that can react with FITC and ALF. Available
labeling sites would be distributed on Fer and longer labeling times would result in reaction of
more of the available sites. However, not all Fer molecules label equally, so they form isomers
with different charge-to-size ratios primarily due to charge change. These isomers should have
closely related electrophoretic mobilities and would migrate as a broad, unresolved band in µCE.
Therefore, limited site labeling of Fer with short reaction times offers the opportunity for a
narrower peak which can result in better resolution in separation with other PTB biomarkers.
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Figure 4.8 Microchip electropherograms of 500 nM Fer labeled with ALF 488 (black) and FITC (red). (A)
20 min incubation, and (B) overnight incubation.

Finally, FITC-labeled PTB biomarker mixtures were separated by µCE as shown in Figure
4.9. All mixtures were separated in less than 2 min, and provided adequate resolution to include
other PTB biomarkers with different mobilities in the future. The impurity peak in the
electropherograms likely resulted from breakdown of peptides into smaller fragments during
labeling or other conditions. Fragments smaller than 2 kDa were removed during the dye filtration
process, while larger fragments would appear as impurities. Peptides 2 and 3 were not used in the
same mixture since their mobilities are similar, as both peptides have the same amino acid
sequence and only differ in the oxidation of a methionine in peptide 3. Peptides 2 and 3 might be
resolved by labeling each one with a different dye (i.e., FITC and ALF) that would result in a
greater difference in charge-to-size ratio. Alternatively, different buffer pH might also change
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charge-to-size ratios; or the oxidized methionine could be alkylated selectively to change peptide
3’s charge-to-size ratio.16
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Figure 4.9 Microchip electrophoresis of PTB biomarkers. (A) Fer and peptide 3. (B) Fer, peptide 1 and
peptide 3. (D) Fer, peptide 1 and peptide 2.
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5. DESIGN AND FABRICATION OF AN INTEGRATED PUMP AND VALVE SOLIDPHASE EXTRACTION AND MICROCHIP ELECTROPHORESIS SYSTEM
5.1 INTRODUCTION
Microfluidics allows integration of many laboratory processes on a single platform to
provide complete analysis.1-2 These micro total analysis systems (µTAS) include processes like
sample preparation, analyte separation, and detection.3 Sample preparation including
microdialysis, extraction, purification, preconcentration, and on-chip derivatization such as
fluorescent labeling, consumes considerable time in analyses;4 therefore, its integration is
significant. Integration of sample preparation with other processes offers advantages of high
throughput, automation, and faster analysis compared to traditional methods.5
Solid-phase extraction (SPE) is a common sample preparation method6 explored for
integration in microfluidic systems,7 especially reversed-phase and affinity SPE.8-9 Reverse-phase
SPE utilizes hydrophobic interactions between the sample and solid support.10 A solid support can
be built in microfluidic channels by either particle packing or monolith fabrication.11 Monoliths
are gaining popularity because of the ease of on-chip fabrication and ability to tune structure by
adjusting the synthesis conditions.12 Monoliths can be made with alkyl chains such as butyl (C4),
octyl (C8), lauryl (C12) or octadecyl (C18) for reversed-phase applications.13 This chapter focuses
on the design and fabrication of a pressure-driven, reversed-phase SPE and microchip
electrophoresis (µCE) integrated system. The application of this system will be covered in Chapter
6. Herein, C8 monoliths are made to capture and enrich samples and perform on-chip covalent
labeling with a fluorescent dye. As reversed-phase SPE involves use of organic solvents to elute
sample from the solid support, an organic solvent compatible material, cyclic olefin copolymer
(COC), is used for microchip fabrication. Furthermore, a peristaltic pump and pneumatic valves
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are integrated in the system to allow controlled manipulation of fluids. The integrated SPE and
separation system described in this chapter comprises parts B-C of the microfluidic system in
Figure 5.1, which will be used for the complete analysis of pre-term birth (PTB) biomarkers.

Figure 5.1 Schematic of a pump and valve integrated microfluidic system for complete analysis of PTB
biomarkers. (A) Immunoaffinity extraction module. (B) SPE and on-chip labeling module. (C)
Electrophoretic separation module.

5.2 MATERIALS
The integrated device is a four layer structure consisting of two polydimethylsiloxane
(PDMS) and two COC layers. A single-side-polished 100 mm Si wafer (Desert Silicon, Tempe,
AZ) with <100> orientation is used to make fluidic and control layer templates. PDMS base and
curing agent kit used for fluidic and control layer fabrication is obtained from Dow Chemical
(Midland, MI). Tridecafluorooctyltrichlorosilane (UCT, Bristol, PA) is used to prime control and
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fluidic templates to prevent sticking of cured PDMS to Si. Microfluidic channels are enclosed in
top and base COC (Zeonor 1020R, Zeon Chemicals, Louisville, KY). Octylmethacrylate (OMA)
and Tween 20 are obtained from Scientific Polymer (Ontario, NY) and Mallinckrodt (Paris, KY),
respectively.

Ethylene

glycol

dimethacrylate

(EGDMA,

98%),

2,2-dimethoxy-2-

phenylacetophenone (DMPA, 99%), 1-dodecanol (98%), cyclohexanol, and 2-propanol (IPA) are
obtained from Sigma-Aldrich (St. Louis, MO). A SunRay 600 UV lamp (Uvitron International,
West Springfield, MA) is used to polymerize monoliths. A biopsy punch (Miltex, York, PA) is
used to make 2.5 mm diameter reservoirs in PDMS layers. Blunt-end, 1.5”-long, 22-gauge needles
are obtained from Jansen Global (Santa Barbara, CA) to punch holes in the control PDMS layer.
Circuit board drill bits (550 and 200 µm diameter) are purchased from MSC Industrial Supply
(Melville, NY) to make holes in top COC plates.
5.3 METHODS
5.3.1 Solid-phase extraction module
The SPE module is a multi-layer structure, made up of elastomeric and thermoplastic
materials (see Figure 5.2). An elastomeric material, PDMS, is used for making pneumatic valves
and the peristaltic pump, as shown in Figure 5.2A-B. Reservoirs 1, 2, and 3 are used to introduce
buffer, sample, and eluent, respectively, and waste is collected in reservoir 4. A pneumatic valve
on each inlet helps in regulating the flow of fluid from the reservoir and enable automation. The
peristaltic pump, placed after the junction, pushes fluid through the fluidic channel into the COC
reservoir. Each pneumatic valve is 150 µm wide and spaced at a 150 µm pitch to make a threevalve peristaltic pump. This configuration of peristaltic pump generates an approximate flow rate
of 12 nL/min for 85% v/v acetonitrile at a 40 Hz actuation frequency. The COC channel contains

105

a C8 monolith for reversed-phase SPE. Reservoirs connect the COC channel to the fluidic channel
in the PDMS layer and enable integration.

Figure 5.2 Design and fabrication of the SPE module. (A) Device schematic, 1: buffer, 2: sample, 3: eluent,
and 4: waste reservoir. (B) Photograph of a completed device; scale bar is 5 mm. (C) Schematic showing
assembly process.
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Each layer of the SPE module is fabricated separately. Fluidic and control Si templates are
fabricated using photolithography and wet etching as shown in Figure 5.3. Four-inch Si wafers
cleaned in buffered oxide etchant (BOE, Transene, Danvers, MA) for 30 s and baked at 150 oC for
15 min are used to make templates. Cleaned Si wafers are exposed to hexamethyldisilazane
(HMDS) vapor at 65 oC for 5 min to coat the surface. Then, photoresist (AZ 50XT, AZ Electronic
Materials, Branchburg, NJ) is spin coated on the fluidic and control wafers to make 13.5 and 20
µm thick photoresist layers, respectively. Photoresist-coated wafers are soft baked at 60 oC for 10
min to degas the photoresist layer and subsequently at 125 oC for 3 min. Baked control and fluidic
wafers are cooled in air for 2 min and placed in a box to rehydrate the photoresist for 40 min.
Photoresist rehydration is a crucial step that prevents cracking. Then, the fluidic and control wafers
are exposed to UV light through a clear-field Cr mask in a UV aligner (Karl Suss America,
Waterbury, VT) to transfer mask features into the photoresist layer. Exposed wafers are developed
in diluted MIF 400K developer (AZ electronics, Somerville, NJ) for 3-4 min to form fluidic and
control channel features. The developed fluidic wafer is heated at 125 oC for 10 min to reflow
photoresist and form rounded features. A post development bake increases the fluidic channel
height to ~18 µm. Finally, the fluidic and control layer feature heights are confirmed using an
Alpha Step 200 profilometer (Tencor, Mountain View, CA).
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Figure 5.3 Schematic showing fabrication of fluidic and control layer templates.

Next, fluidic and control template features are transferred into PDMS by soft lithography
as shown in Figure 5.4. PDMS base and curing agent are mixed in 4:1 and 20:1 for the fluidic and
control layers, respectively, and degassed for 30 min in vacuum. In the meantime, fluidic and
control templates are silanized by exposing to tridecafluoro-trichlorosilane vapor at 80 oC for 10
min. A 4” diameter PVC ring has its edges coated with degassed control layer PDMS mixture, and
the silanized control template is placed on it to make an airtight seal. The PVC ring prevents PDMS
leakage and maintains constant material height during polymerization. The assembly is baked on
a hot plate at 80 oC for 10 min to polymerize PDMS. Next, control layer PDMS mixture is poured
in the center of the control template and allowed to spread uniformly to cover the features. The
silanized fluidic template is spin coated with fluidic layer PDMS mixture to form a uniform coating
of 25-28 µm thickness. Finally, the fluidic and control layer PDMS is cured in an oven at 80 oC
for 1 hour. Cured control layer PDMS is peeled off from the template and diced into individual
devices, and then holes are punched using a 22-gauge blunt end needle to connect control channels
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to pressure tubing. Hole-punched control PDMS is cleaned using IPA, stamped with curing agent
coated on a Si wafer, aligned and contacted to the fluidic PDMS layer while observing in a
modified stereomicroscope. Aligned PDMS layers are baked at 80 oC for 1 hour to form a bond.
Then, the bonded PDMS layers are peeled off from the fluidic templates, and reservoir holes are
made using a biopsy punch.

Figure 5.4 Schematic showing fabrication of control, fluidic and COC layers for the SPE unit.

In parallel, the COC channels are made as shown in Figure 5.4. A 4” Si template is prepared
to make COC channels as described in Chapter 4.3.1 and Figure 4.1; the template is wet etched in
40% aqueous KOH solution at 70 oC to yield 18-20 µm tall features. A 1 mm thick 6” x 6” COC
plate is cut into 3.5 x 2.5 cm2 pieces using a bandsaw, and edges are smoothed with a razor. Etched
Si template features are then hot embossed in COC at 138 oC for 26 min. Holes are drilled in a 1mm-thick COC plate using a 0.54 mm diameter drill bit, and the plate is reflattened at 110 oC for
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20 min. COC with imprinted features is aligned and thermally bonded to the drilled COC plate at
110 oC for 23 min, and the bonded COC device edges are sealed using cyclohexane. A C8 monolith
is formed inside the COC channel as described in the next section of this chapter. Finally, PDMS
and COC structures are bonded together as shown in Figure 5.2C. Briefly, COC and PDMS are
cleaned with IPA and dried using a N2 gun. The COC device surface is further cleaned in an O2
plasma (Planar Etch II, Technics, Osaka, Japan) for 4 min at 200 W, and the PDMS is stamped in
curing agent coated on a wafer. Finally, COC and PDMS are aligned and thermally bonded at 80
o

C for 1.5 h. Figure 5.2B shows a photograph of a complete device.

5.3.2 Octylmethacrylate monolith
SPE is performed on a solid porous support formed inside a COC channel by in-situ UV
photopolymerization of monomer, porogens and crosslinker mixture in the composition shown in
Table 5.1. A schematic showing monolith fabrication in a COC channel is shown in Figure 5.5A.
Monolith solution with the composition in Table 5.1 and having a total mass of 1.18 g is prepared
by weighing in a 10 mL glass vial. The mixture is vortexed for 30 s and sonicated for 5 min. Next,
12 mg of DMPA is weighed and added to the monolith mixture, followed by vortexing and
sonication for 10 min. After that, the mixture is purged with N2 for 5 min to remove dissolved gas.
The COC channel is rinsed with IPA and vacuum dried followed by the introduction of degassed
monolith mixture using a 2 µL pipette. The solution flows through the COC channel due to
capillary action, and excess solution is removed from the inlet reservoir. A Cr mask with multiple
openings is used to cover the solution-filled COC channel, exposing the desired channel area where
the solution is polymerized. The assembly is stabilized using electrical tape, another COC device
of similar thickness is attached to the mask to maintain uniform height, and everything is placed
in a SunRay 600 UV floodlight chamber at a 14” distance from the bulb. The UV lamp is turned
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on at 50 mW/cm2, and the device is exposed for 11 min. Then, the device is removed from the Cr
mask, reservoirs are rinsed with IPA and unpolymerized monolith solution is removed by vacuum.
The monolith is further rinsed with IPA to remove any unpolymerized components left on the
surface, followed by water rinsing to remove IPA. A photograph of a polymerized monolith in a
COC device is shown in Figure 5.5B (left).
Table 5.1 Composition of C8 monolith. All percentages are by mass.

Monomer

Octylmethacrylate (23%)

Cross linker

Ethylene glycol dimethacrylate (11%)

Photoinitiator

2,2-Dimethoxy-2-phenylacetophenone (1%)

Porogens

Cyclohexanol (25%), 1-dodecanol (23%), and Tween 20 (17%)

Figure 5.5 C8 monolith fabrication. (A) Schematic showing fabrication steps. (B) Photograph and SEM
image showing internal structure.

111

The morphology of a bulk-polymerized C8 monolith is observed using a Philips XL30 FEG
environmental scanning electron microscope (ESEM) from FEI (Hillsboro, OR, USA). Sample
preparation includes polymerization of 200 µL of monolith solution in a polypropylene tube under
similar UV exposure. The polymerized monolith mass is broken into small pieces and mixed in
IPA on a shaker overnight to remove unpolymerized solution. Finally, the monolith is stored in
vacuum overnight to form a dry, porous structure. The dried monolith is placed on a carbon taped
stub and examined under ESEM for internal structural information as shown in Figure 5.5B (right).
ESEM imaging shows that fused structures are formed with varying pore sizes, which allow liquid
flow through the monolith structure.
5.3.3 Microchip electrophoresis
A three-layer µCE device is fabricated similar to the SPE module, except for the COC
channel and monolith fabrication. The layout and an actual device are shown in Figure 5.6. A
three-valve peristaltic pump and a set of four pneumatic valves are incorporated around a ‘T’ shape
design channel network to manipulate fluids using pressure. Valves are 250 µm wide, and are
spaced with a 120 µm gap in the peristaltic pump. Reservoir 1 is used to introduce fluorescenctly
labeled analyte solution using the on-chip peristaltic pump. A set of four pneumatic valves
surrounding the injection intersection is used for capturing the sample plug. Reservoirs 3 and 4 are
filled with separation buffer and sample waste is collected in reservoir 2. During electrophoresis,
reservoir 3 is kept at ground while high voltage is applied at reservoir 4. Sample plug formation
depends on factors such as valve spacing at the intersection, solution flow rate, and intersection
geometry. A fixed valve spacing of 300 µm from the intersection to each valve is used. A different
study is ongoing to optimize the valve spacing for the final device.14 Solution flow rate can be
controled using pump actuation frequency, and a simple “T” intersection is used in all devices.
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Figure 5.6 Design of separation module. (A) Device schematic, 1: sample, 2: waste, 3: ground, and 4: high
voltage reservoir. (B) Photograph of completed device; scale bar is 7 mm.

The fabrication procedure for the separation module is similar to that for the SPE system,
as shown in Figure 5.7. Fluidic and control templates are fabricated as described in Section 5.3.1.
PDMS base and curing agent mixture are prepared in a ratio of 4.4:1 and 19:1 for the control and
fluidic layer, respectively. All other processes are the same as in Section 5.3.1.
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Figure 5.7 Fabrication of control and fluidic layers for the separation module and their assembly to make
a device.

5.3.4 Integration of the SPE and separation modules
The SPE and separation modules were integrated on a single platform to provide complete on-chip
analysis of PTB biomarkers as shown in Figure 5.8. The SPE design was slightly modified to
simplify the fabrication procedure and increase device yield. Previously, the purpose of using three
inlet channels to the SPE module (Figure 5.2A-B) was to automate device operation. However,
the SPE process requires 8-10 different solutions which makes necessary many sample inlets for
complete automation, making the device design more complex. Therefore, in these initial studies
the SPE design was simplified to have a single inlet to allow preliminary study of integration with
the separation module. The peristaltic pump was also switched to a five-valve configuration from
three valves because the five-valve pump was found to generate a higher flow rate (data are in
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section 6.4). In the integrated design, prelabeled or unlabeled analyte was captured and
concentrated on the C8 monolith. Unlabeled analyte was derivatized fluorescently for detection.
Sample prepared in the SPE unit was released and captured at the injection intersection using
valves, and the captured plug was separated into individual analytes by microchip electrophoresis.
Reservoir 1 was used to introduce sample, dye, buffer, and ACN-buffer mixtures. Reservoirs 2
and 4 collected sample and separation waste, respectively. Reservoirs 3 and 4 were filled with
separation buffer and used to apply voltage along the separation channel during µCE.

Figure 5.8 Design of integrated SPE and separation module. (A) Device schematic, 1: buffer, sample, or
eluent reservoir, 2: waste, 3: ground, and 4: high voltage reservoir. (B) Photograph of completed device;
scale bar is 3 mm.

The fabrication procedure is similar to that for the separation module described in Section
5.3.3. Briefly, control and fluidic PDMS layers are prepared by polymerizing the PDMS base and
curing agent mixture on the templates as shown in Figure 5.9. The control layer is bonded to the
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fluidic layer and holes are punched. COC device fabrication is modified to reduce dead volumes
in the final device. One-millimeter-thick COC is cut into 1x1 cm2 pieces using a bandsaw. Each
1-mm-thick COC piece is thinned to 80-100 µm using a hydraulic press (Carver, Wabash, IN) with
top and base plates heated to 196 oC and ~2 metric tons applied pressure. Thinned COC is again
cut into sizes matching the base COC plate, and holes are drilled using a 200-µm-diameter circuit
board drill bit. The top COC plate is flattened between two glass slides at 110 oC for 25 min and
thermally bonded to the imprinted base COC at 110 oC for 28 min. This new COC device design
allows COC reservoir filling in less than 1 min when the pump is actuated. Then, a C8 monolith
is polymerized in the COC channel as described in Section 5.3.2. Finally, all layers are assembled
and bonded together as shown in Figure 5.10 and described in Section 5.3.1 to make the final
device. A photograph of a completed integrated device is shown in Figure 5.8B.
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Figure 5.9 Fabrication of control, fluidic and COC layers for an integrated device.

Figure 5.10 Schematic showing assembly of an integrated device.
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6.

EVALUATION

OF

AN

INTEGRATED

MICROFLUIDIC

SOLID-PHASE

EXTRACTION AND SEPARATION MODULE
6.1 INTRODUCTION
Analytical techniques are often insensitive to analytes in their crude form.

1-3

Therefore,

sample preparation is an essential step in analysis and can involve processes such as sample
dissolution, matrix removal, enrichment, and chemical derivatization.4 A typical separation
analysis may involve more than ~60% of the time in sample preparation and require large
quantities of solvent (~9x more than the sample volume) and breakable glassware.5-7 Integrating
sample preparation with separation techniques on a microfluidic chip can address these problems;89

however integration is difficult.10 Solid-phase extraction (SPE) is a common, widely used, and

well-studied sample purification and extraction technique for clinical, biological, environmental
and food studies.11 The use of SPE has been growing over liquid-liquid extraction in recent years
because SPE offers simplicity, lower organic solvent consumption (~70% less), and 2x faster
speed.12-13
The use of on-chip SPE in microfluidics allows enrichment of analyte and can improve
detection limits.14-15 Several researchers have integrated SPE and separation techniques in a
microfluidic device. Ramsey et al.15 packed C18-coated silica beads in a microchannel to make an
SPE column and integrated it with micellar electrokinetic chromatography separation on a
microchip. Particle packing required porous plug polymerization in the microchannel to act as a
frit. This integrated device performed an automated sequence of extraction, elution, injection,
separation and detection of two model fluorescent dyes in less than 5 min. However, more complex
and biologically relevant analytes were not demonstrated. Foote et al.16 used a porous silica
membrane to concentrate fluorescently labeled proteins and then separated the enriched proteins
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by microchip gel electrophoresis. However, protein was labeled off-chip, which is the most timeconsuming step in sample preparation for laser induced fluorescence detection. Long et al.17 used
a C18-bead-packed micro SPE column to enrich rhodamine 123 and FITC-labeled ephedrine in a
polydimethylsiloxane (PDMS) device. Enriched samples were injected by applying a pulse of
voltage through a nonporous membrane separating the SPE column and separation channel.
However, off-chip labeled simple molecules were demonstrated, two external syringe pumps were
needed for fluid handling, and the SPE column required frits and particle packing. Kang et al.18
demonstrated online extraction, electrophoretic separation, and electrochemical detection of
dopamine in an integrated multilayer device. A polymeric monolith was fabricated in PDMS and
micro valves were used to control fluid flow. However, the device was operated using an external
pump, and the extracted sample was eluted into a reservoir that caused sample dilution before
injection. In summary, previously reported studies on integration of sample preparation and
separation demonstrated simple model analytes, off-chip fluorescent labeling, and external pumps
for flow. In contrast, a truly integrated microfluidic device should perform all sample analysis
steps including extraction, enrichment, labeling, and separation on a single microchip with on-chip
fluid control.
In microfluidic devices, liquids can be manipulated or handled using electrokinetic or
pressure-based methods.19 Both methods have their merits and demerits. For example, device
fabrication is simple and only requires voltage controllers for electrokinetic operation, but this
method is limited by analyte charge bias, Joule heating, and sensitivity to variations in both fluid
composition and channel wall coatings.19-20 On the other hand, in pressure-driven systems, a wide
range of fluids can be pumped with precise control of fluid volumes, and injection is not biased.2021

There are many types of pumps for pressure-driven operation in microfluidics; they involve
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membranes, electroosmotic flow (EOF), electrohydrodynamics, magnetohydrodynamics or
external components.21 Magnetohydrodynamic and EOF pumps cannot be used for pumping
nonionic liquids, and require either magnets or applied voltages for operation. Use of external
pumps counteracts the ideal of miniaturization in microfluidics. In contrast, membrane-actuated
peristaltic pumps allow pumping of precise fluid volumes and easy integration into microfluidic
devices. Flow rates and direction are also easy to control with peristaltic pumps. Therefore, in this
study, a membrane-actuated peristaltic pump and pneumatic valves are used to allow pressureactuated sample handling and manipulation.
Here, acrylate-based monoliths with octyl (C8) surface functional groups are used for onchip SPE of proteins and peptides. Extracted protein is derivatized on-chip with fluorescent dyes
to enable detection. On-chip extracted and labeled ferritin (Fer) samples are separated in a
microchip electrophoresis (µCE) module. This study demonstrates integration of sample
preconcentration, fluorescent labeling, and separation all on a single platform.
6.2 MATERIALS
Food dyes (Great Value, Walmart, Bentonville, AR) are filled into microfluidic channels
for visual inspection of device operation. Solenoid valves (Clippard, Cincinnati, OH) connected to
the building compressed air supply are used to actuate on-chip valves. The control channel and
solenoid are connected using microbore polytetrafluoroethylene (PTFE) tubing (0.022” ID x
0.042” OD, Cole Parmer, Vernon Hills, IL) and hypodermic stainless steel pins (0.025” OD x
0.018” ID x 0.394'' long, Type 304, New England Small Tube, Litchfield, NH).
Hydroxypropylcellulose (HPC), phenylalanine-alanine (FA), and glycine-glycine-tyrosine-alanine
(GGYR) are obtained from Sigma Aldrich, St. Louis, MO. Fer is purchased from EMD Millipore,
Billerica, MA. Fluorescein isothiocyanate (FITC) and Alexa Fluor 488 5-tetrafluorophenyl ester
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(ALF), obtained from Life Technologies, Carlsbad, CA, are used to fluorescently label samples.
The fluorescent labeling procedure, described in Chapter 2.2.1, is used to label Fer with FITC and
ALF. FA and GGYR are labeled as follows: sodium bicarbonate buffer (BCB, 100 mM) is
prepared by dissolving 420 mg NaHCO3 (EMD Chemical, Gibbstown, NJ) in deionized (DI)
water, and the pH is adjusted to 9.1, as recommended for overnight labeling, using 6 M NaOH
(Spectrum, Gardena, CA). FA and GGYR solutions are prepared in BCB, each containing 10 mM
peptide and 1.6 mM FITC. Peptide and FITC mixtures are incubated overnight at room
temperature for labeling. For on-chip labeling, BCB is diluted to 10 mM and the pH is raised to
9.8 (higher pH favors rapid on-chip labeling). Solid-phase elution buffers are prepared containing
100, 90, 70, 50, and 30% v/v acetonitrile (ACN, Sigma Aldrich) in 10 mM BCB. Electrophoretic
separations are performed using 20 mM BCB (pH 9.8), 30 mM NaCl, and 0.05% HPC.
6.3 METHODS
6.3.1 Device characterization
Devices fabricated in Chapter 5 are initially tested using food dye solutions prepared in 10
mM BCB and 85% ACN. Device design and operational aspects such as pneumatic valve actuation
pressure, pump flow rate, dead volume, flow through monolith and sample plug capture are
studied. Figure 6.1A-B shows the SPE module layout; the control channels are filled with green
dye, and three inlet fluidic channels lead into a 0.53-mm-wide and 1-mm-deep cyclic olefin
copolymer (COC) reservoir. Features in the control layer regulate the flow through fluidic
channels; three control channels placed in series form a peristaltic pump as shown in Figure 6.1B.
Figure 6.1C shows the SPE experimental setup; the green dye filled tubing connects control
reservoirs with external solenoids that cause valve actuation. Solenoid operation is controlled using
a computer program written in LabVIEW.
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Figure 6.1 Initial SPE module design. (A) Photograph showing sample, buffer, and eluent inlet channels
and pneumatic valves. (B) Photograph showing three-valve peristaltic pump and fluidic channel connected
to a reservoir to access a C8 monolith in the COC layer. (C) Final device on an inverted microscope,
connected to external tubing and solenoids (not shown) to actuate valves.

Figure 6.2A shows a schematic and photograph of open fluidic and control channels
separated with a 6-8 µm thick flexible membrane. Several fluidic channel heights (7-16 µm) are
tested for a 65-µm-wide fluidic channel, and 25-50 psi is applied in the control channel to
completely close pneumatic valves. Figure 6.2B shows a schematic and photograph of membrane
actuation into the fluidic channel, which stops the flow. Fluidic channel inlet reservoirs are filled
with red dye in 85% ACN, and the pump is actuated at 40 Hz for 8 h to evaluate material
robustness.
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Figure 6.2 Pneumatic valve structure. (A) Open valve configuration (left) schematic showing vertical crosssection, and (right) photograph of an actual valve. (B) Closed valve configuration (left) schematic, and
(right) photograph of an actual valve.

ACN and buffer flow through the monolith is tested in the SPE module with a three-valve
pump. The pump actuated at 40 Hz is used to flow red dye prepared in 85% ACN through the
monolith for 15 min, and rinse solution containing 85% ACN for 1 h to elute. Next, green dye
prepared in 10 mM BCB is pumped for 30 min to replace 85% ACN in the monolith structure.
The SPE module is integrated with the separation module to allow on-chip extraction,
labeling and separation. Three- and five-valve peristaltic pumps are fabricated on chip using 250µm-wide control channels, spaced at a 120 µm distance. Figures 6.3A-B show a five-valve
peristaltic pump and a set of four pneumatic valves built in the integrated design. Four pneumatic
valves are placed around the injection intersection with a 300 µm distance from the intersection to
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capture the sample plug prepared in the SPE module. Figure 6.3C shows the experimental setup
used for integrated device operation. Three- and five-valve pump flow rates are calculated by
recording the time to pump different solutions from the intersection to the sample waste reservoir
(4 mm). Pumps are actuated at 10 and 20 Hz frequencies with ~30 psi applied.

Figure 6.3 SPE and separation module integrated device. (A) Five-valve peristaltic pump in the SPE
module with (left) open and (right) actuated valves. (B) Pneumatic valve arrangement surrounding the
intersection in the separation module; (left) open and (right) actuated. (C) Integrated device on a microscope
stage with dye-filled control channels connected to external tubing.

6.3.2 Protein and dye retention and elution
Fluorescent dye (FITC and ALF) retention and elution from a C8 monolith are studied to
select the least retained dye for on-chip labeling. A five-valve on-chip peristaltic pump operates at
10 Hz frequency, and valves are actuated with ~30 psi to flow solutions. The C8 monolith surface
is conditioned by passing 90, 50 and 30% ACN solutions through the monolith for 5 min followed
by a 5 min 10 mM BCB (pH 9.8) rinse. FITC (1 µM) prepared in BCB is loaded onto the column
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for 10 min, and unretained FITC is rinsed off using BCB. Next, the column is rinsed successively
with eluents composed of increasing amounts of ACN (30, 50, 70, 90, and 100%) in BCB. A
similar experiment is performed on the same device by replacing FITC with 1 µM ALF. Under
illumination from a 488 nm laser, monolith images at each step are recorded using a Photometrics
CoolSNAP HQ2 (Tucson, AZ) cooled CCD camera with 500 ms exposure. Furthermore, to study
the change in monolith fluorescence intensity, average values are measured by drawing a box
(approx. 400 x 110 pixel2) around the monolith using ImageJ software.
Prelabeled Fer is used to study Fer retention and elution on a C8 monolith in the SPE
module. Here, a three-valve peristaltic pump is operated at 40 Hz, and valves are actuated with
~30 psi. The monolith surface is conditioned as described in the previous paragraph. FITC-labeled
Fer (500 nM) is loaded onto the monolith for 5 min and unretained Fer is rinsed off by flowing
BCB. The captured Fer is eluted using eluents composed of increasing amounts of ACN (30, 50,
90 and 100%). Fluorescence images of monoliths are recorded using a CCD with 500 ms exposure
time, as described above.
The effect of three- vs. five-valve pumps on Fer retention and elution in an integrated
device is also studied. First, 200 nM prelabeled Fer is loaded onto a C8 column after column
conditioning for 5 min using a five-valve peristaltic pump operated at 10 Hz, and ~30 psi applied
pressure. The C8 column is rinsed with BCB and the captured protein is eluted by flowing 90%
ACN through the column. Content eluted from the column is detected using a photomultiplier tube
(PMT) detector (Hamamatsu, Bridgewater, NJ) at the injection intersection. A similar experiment
is performed using a three-valve pump operated at 20 Hz, and ~30 psi pressure. 100 nM prelabeled
Fer is loaded onto the column for 15 min and the captured Fer is eluted in 90% ACN.
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6.3.3 Evaluation of acetonitrile effects on peak shape in the separation module
Eluent composed of different percentages of ACN in 10 mM BCB is used for eluting
fluorescently labeled Fer from the C8 column and transports the sample into the separation module
for separation. Therefore, 40 nM FITC samples are prepared in separation buffer with either 90,
70, or 50% ACN to study the effect of ACN concentration in the injection solution on analyte
separation. All FITC solutions are tested in devices lacking a monolith. A three-valve peristaltic
pump operated at 10 Hz and ~30 psi is used to inject sample into the injection intersection for 40
s. During injection, valves on the injection channel are kept open, but those on the separation
channels are closed. Next, the sample plug is captured by closing the injection channel valves,
followed immediately by opening the valves on the separation channel, and applying 1200 V along
it. Fluorescence detection is performed at a 5 mm distance from the intersection using a PMT as
described in Section 6.3.2, with the voltage set to 830 and 2x amplification.
6.3.4 Protein enrichment study
An integrated device with three-valve peristaltic pump is used for prelabeled Fer
enrichment on the C8 monolith. The peristaltic pump is operated at 20 Hz, and the valves are
actuated at ~30 psi. First, the C8 column is conditioned with eluents as described in Section 6.3.2.
Prelabeled Fer (100 nM) is loaded onto the column for 10 min (~300 nL) and monolith
fluorescence images are recorded after each minute. Next, the column is rinsed with 10 mM BCB
for 4 min to wash away unretained Fer. Enriched Fer is eluted from the column using 90% ACN
and captured at the injection intersection using the valves as described in Section 6.3.3. The
captured plug is separated with 700 V applied down the separation column, and the fluorescence
is recorded at 3 mm from the intersection with a PMT having a 780 V setting and 2x amplification.
Finally, the column is rinsed with 100% ACN to completely free the labeled Fer from the C8
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monolith. Electrophoretic separation of 100 nM Fer is also performed under similar conditions
using a pump and valve integrated separation module lacking the C8 monolith; fluorescence is
recorded 5 mm from the intersection.
Enrichment of model peptides (FA and GGYR) on the C8 column is also studied in an
integrated device. A three-valve peristaltic pump is operated at 20 Hz, and ~30 psi is used for
actuating the valves and pump. FA and GGYR (500 nM each) are loaded onto a preconditioned
C8 monolith for 10 min and rinsed with 10 mM phosphate buffer (pH 7.2) to remove unretained
peptides. The enriched peptides are eluted in 90% ACN and captured using four valves as
described in Section 6.3.3. The captured plug is separated into FA and GGYR bands with 700 V
applied along the column length. Fluorescence is detected 4 mm from the intersection using 1010
V as the PMT setting and 2x amplification. The same peptide mixture is also separated in the
separation module without enrichment.
6.3.5 On-chip labeling
On-chip Fer labeling with FITC and ALF is performed in the integrated device shown in
Figure 6.3C. All solutions are introduced from the same reservoir (left side) in the integrated
device. The C8 column is conditioned, and 200 nM unlabeled Fer is loaded for 5 min (~700 nL)
using a five-valve peristaltic pump. Pump operation parameters include 10 Hz actuation frequency
and ~30 psi valve closing pressure. FITC (1 µM) prepared in 10 mM BCB (pH 9.8) is flowed
through the column for 3 min (~400 nL) and allowed to react with retained Fer for 10 min under
stopped flow conditions. Unreacted FITC is rinsed off the column using BCB for 2 min (~300 nL).
The monolith column is rinsed with 50% ACN (~400 nL) to remove any unreacted FITC after the
buffer wash. Labeled Fer is eluted from the column using 90% ACN. Finally, the column is rinsed
with 100% ACN to completely elute any Fer left. A control experiment is run by omitting Fer
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under similar conditions in the same device. Fluorescence images are recorded as described in
Section 6.3.2 using a CCD camera with a 500 ms exposure time.
ALF is used to label Fer on-chip in the integrated device. First, 1 µM Fer is loaded onto a
preconditioned C8 column (see Section 6.3.2 for details) for 7 min (~1 µL) using a five-valve
peristaltic pump operated at 13.3 Hz with ~30 psi applied pressure. Next, 30 µM ALF prepared in
10 mM BCB (pH 10.0) is flowed through the column for 2 min (~300 nL) and allowed to react
with Fer for 25 min. Unreacted ALF is rinsed off using BCB (~450 nL) and 30% ACN (~340 nL).
Finally, the labeled Fer is eluted in 90% ACN, and LIF signal is recorded at the injection
intersection as in Section 6.3.2 with the PMT set at 740 V and 2x gain. A control experiment is
also run on the same device under similar conditions by omitting the Fer loading.
6.3.6 On-chip labeling and separation of ferritin in an integrated device
The schematic diagram shown in Figure 6.4 explains the operation of the integrated device
for on-chip Fer labeling and µCE. All solutions are introduced from the same inlet reservoir using
a five-valve peristaltic pump operated at 10 Hz and ~30 psi. Device operation involves
conditioning the C8 column by flowing 100% ACN for 5 min (~700 nL), 50% ACN for 2 min
(~300 nL), 30% ACN for 2 min (~300 nL), and finally BCB for 5 min (~700 nL). After column
conditioning 1 µM of Fer is loaded for 10 min (~1.4 µL) using a five-valve peristaltic pump (Figure
6.4A). Next, 20 µM ALF is flowed through the column for 2 min (~300 nL) and allowed to react
with the captured Fer for 25 min. Fer is labeled (Figure 6.4B) and unreacted dye is rinsed off using
buffer (~700 nL) and 30% ACN (~300 nL). Labeled Fer is eluted from the column in 90% ACN
into the injection intersection. Valves are opened on the injection channels and closed on the
separation channel during Fer elution. All four valves are closed when the eluted Fer reaches the
intersection at ~20 s and the plug is captured (Figure 6.4C). Finally, the captured Fer plug is
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separated by opening valves on the separation channel and applying 500 V (Figure 6.4D). LIF as
described in Section 6.3.3 is used to detect the separated Fer peak 3 mm down from the
intersection, with a PMT setting of 850 V and 2x amplification. Fluorescence images of the
monolith are also recorded using a CCD with 500 ms exposure time as described in Section 6.3.2.

Figure 6.4 Schematic showing operation of an integrated device. (A) Protein (1 µM) is loaded onto a C8
column using the pump (~10 min). (B) Fluorescent dye (20 µM) is pumped through the column and the
protein/dye mixture is incubated for covalent labeling (~25 min). (C) Labeled protein is eluted using 90%
ACN and captured at the intersection using a set of four pneumatic valves (~1 min). (D) The captured plug
is separated using µCE and detected using LIF (~1 min).

6.4 RESULTS AND DISCUSSION
Preliminary experiments to optimize the device design were performed using food dyes to
visualize flow. Initial studies included PDMS compatibility with ACN, channel dimension
optimization, pump flow rate measurements, and observation of flow through a monolith. The
peristaltic pump was used to pump 85% ACN for 8 h to observe any effects on the cured PDMS.
I found that PDMS didn’t swell in ACN, the pump was still operational after 8 h of actuation, and
no PDMS delamination was observed. Hence, ACN was compatible with PDMS devices. In the
initial SPE module, shallower (<9-µm height) fluidic channels had low device yields due to
blocking with curing agent during device bonding. On the other hand, taller (>10 µm) channels
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required valve actuation pressures above 40 psi, which often caused device delamination.
Therefore, ~9 µm tall fluidic channels were used as they needed valve actuation pressures <40 psi
and channel blocking with curing agent was minimal. In the initial SPE module, the three-valve
pump formed by placing three 150-µm-wide control channels 150 µm apart generated a 12 nL/min
flow rate for 85% ACN solution and filled the 1-mm-deep COC reservoir in ~30 min. Solutions
with dye flowed through a monolith in the SPE module (see Figure 6.5), demonstrating that the
monolith was porous and the on-chip pump could move liquid through.

Figure 6.5 Study of flow through a C8 monolith in the SPE module. (A) Empty monolith, (B) red dye flow,
(C) 90% ACN elution of red dye, and (D) green dye flow.

In the integrated design, the fluidic channel was 120 µm wide and 18 µm tall to prevent
channel blockage during bonding. To increase the pump flow rate in the integrated device, 250µm-wide control channels were fabricated and five control channels were placed with a 120 µm
inter-feature distance to build a five-valve pump. The three-valve pump having dimensions similar
to the five-valve pump was also formed in the integrated design for flow rate comparison. Wider
control channels and a taller fluidic channel resulted in larger displaced solution volumes with
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each valve actuation, and thus produced higher flow rates, as shown in Table 6.1. Such a
configuration also allowed valve actuation pressures <35 psi. The differences in flow rates of
different solutions for three- and five-valve pumps at 20 Hz actuation were caused by incomplete
valve sealing due to the increase in fluid viscosity when the ACN content was decreased. Threevalve pump flow rates at 10 Hz actuation for different solutions did not change significantly
because membrane dynamic deflection was slower than the actuation rate. Moreover, the use of
thinned (80-100-µm-thick) COC and narrower (200-µm-wide) through holes decreased the dead
volume so the COC reservoir filled in less than 1 min (140 nL/min). The trident fluidic channel
design (Figure 6.1A) was dropped from the SPE module in these studies on integration with the
separation module to simplify the fabrication. This simpler design lacked multiple inlets which
required solution replacement in the single inlet reservoir.
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Table 6.1 Three- and five-valve peristaltic pump solution flow rates at different actuation frequencies.

Solution

20 Hz operation

10 Hz operation

ACN

121 nL/min

*

50% ACN+ 50% Buffer

56 nL/min

*

30% ACN+ 70% Buffer

40 nL/min

*

Buffer

30 nL/min

*

90% ACN + 10% buffer

331 nL/min

135-140 nL/min

50% ACN+ 50% Buffer

276 nL/min

135-140 nL/min

30% ACN+ 70% Buffer

207 nL/min

135-140 nL/min

Buffer

165 nL/min

135-140 nL/min

Three valves

Five valves

* Solution flow rate at 10 Hz actuation for the three-valve pump was not measured because flow was very
slow at 20 Hz operation. Each value given is the average of two measurements done in the same device.

In Figure 6.6A, background-subtracted fluorescence intensities of FITC and ALF on a C8
monolith as a function of retention/elution conditions are plotted. Fluorescence on the monolith
for ALF retention was higher for the initial 2 min, probably because the ALF fluorescence quantum
yield is higher than for FITC.22 After 5 min of loading, the signal from FITC retained on the column
exceeded that for ALF, likely because FITC is more hydrophobic and thus more retained than
ALF. As a result of this hydrophobicity difference, FITC was retained on the column, while most
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of the ALF eluted during the buffer rinse. After rinsing the column with 30% ACN, the ALF
intensity decreased slightly, but did not decrease much more upon rinsing with solutions composed
of higher ACN percentages. In contrast, the retained FITC intensity gradually decreased on
increasing the ACN content in the eluent.
FITC-labeled Fer retention and elution was also studied on a C8 monolith. As shown in
Figure 6.6B, the monolith fluorescence intensity increased as the Fer loading time changed from
3 to 5 min. Longer Fer loading resulted in retention of more Fer on the column due to the
hydrophobic interaction between Fer and the C8 functional groups. Buffer, 30% ACN, and 50%
ACN rinses had a small effect on the column fluorescence because Fer was strongly retained.
However, the column fluorescence decreased significantly when the monolith was rinsed with 90
and 100% ACN. The high organic content of the 90-100% ACN eluent reduced non-polar
interactions between Fer and the C8 functional groups and released the retained Fer. From this
study of dye and Fer retention/elution on C8 monoliths, I concluded that ALF would be a good
molecule for on-chip Fer labeling. Additionally, ALF conjugates are more photostable and provide
a higher fluorescence quantum yield than FITC, further supporting this choice.22 Rinsing the
column with eluent containing up to 50% ACN elutes most of the ALF without affecting Fer
retention; thus, the elution of on-chip labeled Fer in 90% ACN can be done with minimal free dye.
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Figure 6.6 Evaluation of dye and Fer retention/elution in a C8 monolith in an SPE unit. (A) Backgroundsubtracted fluorescent intensity on a C8 monolith for retention and elution of ALF (red) and FITC (blue).
(B) Background-subtracted fluorescent intensity of prelabeled Fer on a C8 monolith under conditions for
retention and elution.
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Prelabeled Fer was loaded onto a C8 monolith using three- and five-valve peristaltic pumps
in integrated devices (Figure 6.3C). Fluorescence images on the C8 monolith at different stages of
the process are shown in Figure 6.7A. Loading of the labeled Fer on the C8 monolith increased
fluorescence signal, while elution of the retained Fer from the monolith in 90% ACN lowered the
monolith fluorescence. Fer eluted in 90% ACN using a five-valve peristaltic pump (blue trace in
Figure 6.7B) resulted in a narrower, taller peak with a faster elution time. On the other hand, the
Fer peak was broadened and eluted later when a three-valve pump (red trace in Figure 6.7B) was
used. The faster flow rate produced by the five-valve pump compared to the three-valve pump
(Table 6.1) reduced the longitudinal dispersion of the Fer band before its detection at the
intersection. Narrower, taller peaks will allow capture of more of the eluted Fer at the intersection
with a higher concentration, which should result in better separation in the µCE module. The noise
in the peaks in Figure 6.7B is due to pulsatile flow of the peristaltic pump where photobleaching
occurs during the time between actuations.
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Figure 6.7 Fer retention and elution on a C8 monolith. (A) C8 monolith CCD images of fluorescence (left)
before, (middle) after loading Fer, and (right) after a 90% ACN rinse using a five-valve pump. (B) Plots
showing PMT detection (at the separation unit’s intersection) of prelabeled Fer eluted in 90% ACN from
the C8 monolith. One and two hundred nM Fer retention and elution were performed using (red) three- and
(blue) five-valve peristaltic pumps, respectively.

Sample prepared in the SPE module is transported to the separation module in high ACN
content eluent. Therefore, I evaluated the effects of ACN in the injected sample on separation
quality using a model molecule (FITC). In Figure 6.8, FITC peak height increased and peak width
decreased as the amount of ACN in the injected sample solution increased. Moreover, having ACN
in the sample solution reduced the peak migration time by 40%.The presence of ACN in the sample
plug lowered the conductivity and resulted in sample stacking, which produced narrower peaks,
shorter migration times, and an increase in peak heights.
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Figure 6.8 Microchip electropherograms showing differences in peak shape and migration of 40 nM FITC
in different concentrations of ACN in the injected solution.

The enrichment capability of the SPE module was evaluated using labeled Fer. Fluorescent
images on a C8 monolith were recorded under different Fer enrichment conditions (Figure 6.9A).
Fluorescence became brighter as the Fer loading time increased, due to an increase in the number
of Fer molecules captured. For quantitative comparison, monolith fluorescence was calculated
from these images as described in Section 6.3.2 (see Figure 6.9B). Fluorescence increased steeply
for the first 4 min and then gradually until 8 min; after 8 min the fluorescence reached a plateau.
The rapid increase in fluorescence intensity at the beginning of Fer loading resulted from the
availability of a large number of C8 functional groups to capture Fer. Over time, the number of
available surface functional groups decreased due to retained Fer, leading to a more gradual
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increase in Fer retention. From 8-10 min, almost all the available sites were occupied by retained
Fer (i.e., column saturation), so further retention was limited. A buffer rinse had almost no effect
on monolith fluorescence because Fer was strongly retained on the C8 column. However, monolith
fluorescence significantly decreased on rinsing the monolith with 90% and 100% ACN. Increased
organic content in the eluent displaced the Fer molecules from the C8 functional groups. I also
quantified Fer enrichment on the C8 monolith using fluorescence intensity measurements. The
fluorescence of 100 nM Fer in a channel of the same dimensions but lacking monolith was
measured as described in Section 6.3.2. The ratio of Fer fluorescence on the monolith after the
buffer rinse step to that in the channel lacking a monolith showed that Fer was enriched ~80-fold
on the C8 column. Such sample enrichment can help in improving detection limits.
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Figure 6.9 Fer retention with time in a C8 monolith. (A) Fluorescent CCD images under different
conditions of Fer retention or elution. (B) Plot showing fluorescent intensity on a C8 monolith with different
loading times and after elution.

I next demonstrated extraction, enrichment, and elution coupled to electrophoretic
separation in an integrated device. Labeled analyte was captured on the monolith, eluted in 90%
ACN into the injection intersection, and then injected and separated by µCE. Figure 6.10A shows
separation of 100 nM Fer after on-chip enrichment; Figure 6.10B shows 100 nM Fer separation
without enrichment. The Fer peak height increased ~70x after enrichment. Fer enrichment in the
electrophoretic separation was very close to the 80x enrichment factor calculated using monolith
fluorescence. The enriched Fer peak migration time was faster compared to the one for Fer without
enrichment because detection was performed close to the injector. Moreover, the presence of ACN
in the enriched Fer plug decreased the migration time as shown in Figure 6.8. A mixture of FA
and GGYR was also enriched on a C8 column, eluted, injected, and separated by µCE similar to
Fer. Figure 6.10C shows separation of FA and GGYR after on-chip enrichment; Figure 6.10D
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shows FA and GGYR separation without enrichment. The FA and GGYR peaks increased
approximately 3- and 11-fold after enrichment, respectively. FA and GGYR peptides are smaller
than Fer, are not as hydrophobic, and are less retained, resulting in lower enrichment. Overall, the
integrated device showed promising results for peptide and protein enrichment for electrophoretic
separation.
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Figure 6.10 Microchip electropherograms showing the effects of on-chip sample enrichment. (A)
Electrophoretic separation of Fer (100 nM) with enrichment on a C8 monolith and (B) without enrichment.
(C) Electrophoretic separation of a mixture of two model peptides, FA and GGYR (both 500 nM), with
enrichment on a C8 monolith and (D) without enrichment.
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On-chip Fer labeling with FITC and ALF was evaluated in an integrated device. Figure
6.11A shows fluorescence images of a monolith with or without retained Fer during various steps
of on-chip labeling using 1 µM FITC. Monolith fluorescence was measured as described in Section
6.3.2 and plotted as function of labeling conditions (Figure 6.11B). The monolith fluorescence
intensities with or without Fer were almost the same after loading FITC. However, on rinsing the
column with buffer and eluent with 50% organic content, fluorescence on monoliths without Fer
loaded decreased more compared to ones with loaded Fer. The retained Fer on the monolith reacted
with FITC covalently, which reduced the elution of FITC and resulted in higher fluorescence signal
compared to a column without Fer. The intensity differences on these columns confirmed the
labeling of Fer.

Figure 6.11 On-chip labeling of 200 nM Fer using 1 µM FITC. (A) CCD images of fluorescence on the C8
monolith under different conditions of labeling. (B) Fluorescent intensity measurements on the C8 monolith
during the FITC labeling process for columns having (blue) 200 nM Fer or (red) no Fer loaded.

Fer was also labeled with ALF in an on-chip monolith, and the eluted band was detected
at the intersection using LIF, as described in Section 6.3.5. Figure 6.12 shows the fluorescent bands
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eluted in 90% ACN from a monolith with 1 µM Fer loaded (black trace) or no Fer loaded (red
trace). A much larger peak resulted from the elution of labeled Fer, compared to when no Fer was
loaded and only ALF retained after the rinse was eluted. In future studies, either a lower ALF
concentration should be used or the column should be rinsed longer after the labeling reaction to
limit the amount of interfering unreacted ALF.
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Figure 6.12 PMT detection of fluorescence from pressure-based elution of 30 µM ALF 488 loaded on a
C8 monolith in the absence of Fer (red), and of 1 µM Fer labeled on-chip with 30 µM ALF 488 (black).

Finally, Fer was labeled on-chip using ALF, and then the labeled Fer was separated in the
separation module to demonstrate successful integration of SPE, labeling and electrophoresis.
Figure 6.13A-B shows monolith fluorescence images and average intensity measurements under
different on-chip Fer labeling conditions. Here, the column was rinsed longer (5 min) with BCB
and 30% ACN than in Figure 6.12 to remove more of the unreacted ALF. After labeling of 1 µM
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Fer on-chip with 20 µM ALF, the labeled Fer was eluted in 90% ACN into the separation module
and separated as shown in Figure 6.13C, resulting in a relatively narrow peak for the on-chip
labeled Fer. The shorter incubation time (25 min) compared to off-chip labeling (24 h) possibly
resulted in labeling of fewer amine groups on Fer (see Chapter 4.4) which led to a narrower peak.
The small co-eluting peak could be one of the Fer isoforms formed during labeling. Moreover,
peak tailing was caused by protein adsorption and could be reduced by increasing the HPC
concentration in the µCE buffer. Additionally, detection was done 3 mm from the injector, and a
band eluted in 90% ACN was injected, both of which can also result in narrower peaks. This study
is the first demonstration of integrating pressure-loaded on-chip SPE, fluorescence labeling,
elution, and electrophoretic separation on a single microfluidic-based platform.
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Figure 6.13 On-chip retention, labeling, elution and electrophoretic separation of 1 µM Fer in an integrated
device. (A) C8 monolith fluorescence images during different steps of on-chip labeling and elution. (B) C8
monolith background-subtracted fluorescence measurements during on-chip labeling and elution. (C)
Electropherogram of on-chip labeled Fer eluted from the monolith in 90% ACN, captured in the injection
intersection and then separated.
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7. CONCLUSIONS AND FUTURE WORK
7.1 CONCLUSIONS
7.1.1 Thin-film microfabricated nanofluidic arrays for size-selective protein fractionation
A nanosieving system was developed and tested for size-selective protein fractionation. I
modified previous fabrication procedures to make devices more reproducibly and with channel
heights down to 15 nm. These improvements enabled me to study the effects of protein size and
concentration on distribution between a height step and the nanochannel exit. The protein
distribution at a nanoscale opening depended on protein diameter and opening size: as the protein
diameter increased from 3.5 to 17 nm for devices having the same height step, an increase in the
trapped/total (T/t) ratio was obtained, until height steps were much larger than the protein diameter.
For some proteins, the highest concentrations led to an increase in the T/t ratio relative to lower
concentrations. I also helped in developing a model, predicting the trapping behavior of rigid
spherical particles at height steps, which provided good correlation with my experimental data.
Moreover, I demonstrated that changes in buffer ionic strength altered the protein trapping
behavior, because of changes in the electric double layer thickness. This effect could be further
explored to tune the effective opening size of fixed height step nanochannels for size-dependent
trapping of different size molecules. These results lay the experimental and theoretical foundation
for separating proteins of different sizes in nanosieving systems.
7.1.2 Increasing protein signal using heat-treated thin-film microfabricated nanochannels
In Chapter 3, a heat-treatment method was developed to reduce protein interactions with
SiO2 and Ta2O5 surfaces. Decreased surface interactions resulted in improved signal from
hemoglobin and catalase at the exits of 100-nm-tall SiO2 and Ta2O5 nanochannels. Ta2O5
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nanochannels showed a more consistent and greater increase in protein signal after heat treatment
compared to SiO2 channels. As existing methods to reduce non-specific protein adsorption are
problematic with nanochannels, this method can support the development of nanofluidic-based
systems for protein analysis. This work could also be extended to other nanochannel materials
such as Al2O3 and Si3N4 to explore heat treatment effects on protein signal in these systems.
7.1.3 Assessment of off-chip fluorescent labeling of preterm birth biomarkers and separation
using capillary and microchip electrophoresis
A fluorescent dye labeling procedure was developed for preterm birth (PTB) peptide
biomarkers, and labeling was assessed using conventional capillary electrophoresis. An
improvement in labeling was observed on denaturing the peptides and using heat to increase
reaction kinetics. Experiments with ferritin (Fer) showed Alexa Fluor 488 5-tetrafluorophenyl
ester (ALF) is a better label than fluorescein isothiocyanate (FITC). However, labeling for longer
reaction times broadened the Fer peak in microchip electropherograms. Mixtures of PTB
biomarkers were also separated in a polymethylmethacrylate device. FITC-labeled peptide 2 and
3 showed similar migration times in microchip electrophoresis (µCE), but several options are
available to change their migration times and improve the separation. Overall, this study is useful
for the on-chip labeling and separation of PTB biomarkers in an integrated device.
7.1.4 Design and fabrication of an integrated pump and valve solid-phase extraction and
microchip electrophoresis system
A fabrication process was developed to make multiple-layer solid-phase extraction (SPE)
and µCE devices. On-chip pneumatic valves and a peristaltic pump were formed in an elastomeric
material to enable pressure-actuated sample manipulation. Furthermore, SPE and µCE were
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integrated on a single microchip device to enable automation. In the integrated design, the
thermoplastic layer thickness and hole diameter were reduced to decrease dead volume.
7.1.5 Evaluation of an integrated microfluidic solid-phase extraction and separation module
In Chapter 6, the successful integration of SPE, fluorescence labeling, elution and µCE in
pressure-controlled integrated microdevice was demonstrated. Fluidic and control channel
dimensions were optimized to actuate valves with <35 psi and produce reasonable flow rates. Both
three- and five-valve pumps were evaluated, and better flow rates were obtained with five-valve
pumps. Studies of retention/elution of Fer and dyes established that ALF is a better option for onchip labeling of Fer because the dye is mostly eluted with an aqueous buffer rinse. A five-valve
pump eluted Fer from a C8 monolith in a narrower peak compared to a three-valve pump. Fer was
enriched 80-fold on a C8 monolith in an integrated device, and showed 70-fold enrichment in µCE.
On the other hand, peptides were enriched only 3-10 fold, much less than Fer, due to their lower
hydrophobicity. Fer labeling with FITC and ALF was tested; a significant amount of FITC was
retained on the column, which could hinder the use of high FITC-to-protein ratios. On the other
hand, much less ALF was retained on the monolith even at higher ALF concentrations. Finally,
successful demonstration of an integrated device was accomplished for on-chip retention, labeling,
elution, and separation of a PTB biomarker (Fer). Overall, this study lays the foundation for
devices integrating SPE, fluorescence labeling, elution and µCE for PTB biomarker analysis.
7.2 FUTURE WORK
7.2.1 Automation of an integrated microfluidic SPE and µCE module
In Chapters 5-6, I showed the fabrication and operation of an integrated SPE and µCE
device. However, device operation was not fully automated because it required manual
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replacement of all solutions in a single inlet reservoir. Figure 7.1 shows proposed designs of an
integrated system that can be tested for automated device operation. There are five essential
solutions required to perform SPE and fluorescent labeling on a chip: analyte, dye, rinsing buffer,
dye eluent, and labeled analyte eluent. Therefore, five inlet reservoirs are needed to automate the
process. Figure 7.1A shows a device design in which five inlet channels merge into a fluidic
channel at a single point. My initial SPE design in Figure 6.1A had a problem with bubble
formation at the channel junction during operation, perhaps due to the convergence of several
channels at one point. Therefore, I propose an alternative design in Figure 7.1B, in which the inlet
channels do not meet at a single point, but merge into a fluidic channel with a small (50 µm)
distance between connection points.

154

Figure 7.1 Designs for automation of an integrated SPE and µCE device. (A) Five pneumatically valved
channels converging at a common point in a fluidic channel. (B) Four pneumatically valved channels
merging into a single channel with a 50-µm distance between merging points. (C) Simple-cross injection
intersection with 200-µm valve spacing. (D) Double-T injection intersection with 300-µm offset.
Reservoirs are, 1: labeled analyte eluent, 2: dye eluent, 3: rinsing buffer, 4: sample, 5: dye, 6: sample waste,
7: running buffer, and 8: separation waste.

In a pressure-actuated integrated device, the intersection geometry and valve spacing
govern the efficient loading of sample. There are two different intersection designs that can be
tested to capture the sample plug. My colleague used a simple-cross geometry (shown in Figure
7.1C) and found that a 200-µm valve distance from the intersection produced the best µCE signal
for peptide separations in pressure-driven devices.1 However, in that study, a continuous source of
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sample was available and long injection times (>30 s) were possible, which affected the plug
volume injected into the separation channel for different valve spacings. In an integrated SPE
device, only a limited volume of sample (~25 nL) is eluted from the monolith, with a ~7 mm width.
Such a small sample cannot be injected for >15 s, and with a simple-cross configuration and 300
µm valve spacing (~4 nL), the entire eluted band cannot be captured unless it has less than ~500
µm width. The sample band could be narrowed by reducing dead volumes and using 100% ACN
to elute the labeled sample. In addition, a double-T intersection (Figure 7.1D) could be used to
capture more of the eluted sample band by adjusting the offset length to match the eluted band
length. The use of a double-T intersection geometry could lower the separation efficiency because
a longer sample plug would be injected. However, the presence of eluting solvent in the injected
sample should cause sample stacking as shown in Chapter 6.4, which could compensate for the
loss in efficiency due to the injected plug length.
7.2.2 Automation of an integrated immunoaffinity and µCE module
Similar to the integrated SPE and µCE platform, a microdevice can be fabricated
integrating immunoaffinity extraction and µCE. Optimal device design parameters from Figure
7.1 can be adapted for automated operation, although for this description, I refer to a device design
similar to Figure 7.1A. Figure 7.2 shows an integrated immunoaffinity extraction and µCE device
design with multiple inlet channels to flow different solutions for automated operation. In a
previous study, retained sample was eluted at low pH (2-3),2 which can cause quenching of some
fluorescent dyes. Therefore, to raise the pH of sample eluting from the monolith, I have designed
an intersecting channel after the monolith, as shown in Figure 7.2. Using a three-valve peristaltic
pump, a basic solution can flow into the fluidic channel with the eluting sample and raise the pH
to restore fluorescence. This will facilitate fluorescence imaging, which is especially useful in
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troubleshooting and optimizing device operation. Sample pH neutralization should not be needed
in the final integrated device that combines immunoaffinity extraction with SPE and µCE because
the eluted sample plug will be captured in the SPE module and eluted in a more neutral pH buffer.

Figure 7.2 Immunoaffinity extraction module coupled with µCE. Reservoirs are, 1: antibody, 2: sample, 3:
wash buffer, 4: eluent, 5: blocking buffer, 6: titration solution, 7: sample waste, 8: running buffer, and 9:
separation waste.

7.2.3 Integrated device for PTB biomarker analysis
Once the design, fabrication and operation of the integrated devices in Figure 7.1 and 7.2
are optimized, all three modules (immunoaffinity extraction, SPE, and µCE) will be integrated on
a single platform, as shown in Figure 7.3. The final integrated device should be able to take a raw
clinical sample in and provide PTB biomarker concentrations as the output. PTB biomarkers
retained and purified in the immunoaffinity extraction module will be eluted and captured in the
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SPE module, where those molecules will be labeled, eluted, and separated as described in Chapter
6.3.6. Signal from peaks in the µCE separation will be used to determine the concentrations of
PTB biomarkers in serum samples, which will help in predicting the risk for a PTB. This early
diagnosis should help in initiating therapeutic interventions to delay delivery.

Figure 7.3 Schematic showing integration of immunoaffinity extraction, SPE, and µCE modules on a single
microfluidic platform. Reservoirs are, 1: antibody, 2: sample, 3: wash buffer, 4: eluent, 5: blocking buffer,
6: labeled sample eluent, 7: dye eluent, 8: rinsing buffer, 9: dye, 10: immunoaffinity waste, 11: sample
waste, 12: running buffer, and 13: separation waste.

The integrated system described offers a platform for rapid and sensitive analysis of PTB
biomarkers, which should help in the diagnosis of PTB weeks before contractions begin. The
application of this system is not limited to only PTB biomarkers, but can also be extended to
analyze for many important clinical cancer or other disease biomarkers. Such an integrated system
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would be a significant development in analytical chemistry, truly demonstrating a micro total
analysis system.
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